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ABSTRACT
NANOSECOND PULSED ELECTRIC FIELD INDUCTION OF PROGRAMMED
CELL DEATH IS CELL TYPE DEPENDENT: AN IN VITRO STUDY
Wei Ren
Old Dominion University, 2011
Co-Directors: Dr. Stephen J. Beebe
Dr. R. James Swanson

Nanosecond pulsed electric fields (nsPEFs) present a novel and effective method
for cancer ablation by eradicating the ubiquitous cancer hallmark of apoptosis evasion
and enforcing cancer programmed cell death. To develop nsPEFs as an anticancer
method, a comprehensive understanding of cell death mechanisms is required. The
overall objective of this dissertation is to elucidate molecular mechanisms underlying
effects of nsPEFs on E4 murine squamous cell carcinoma and human T-cell Jurkat clones
that are wildtype, deficient in FADD (AFADD) and deficient in caspase-8 (ACas-8). The
overall hypothesis is that nsPEFs eliminate cancer cells through activating caspasedependent and caspase-independent programmed cell death pathways that originate from
plasma membranes and/or intracellular membranes, especially mitochondria and
endoplasmic reticulum. The specific aims are to: 1) determine whether nsPEFs induce
cell death in E4 cells and Jurkat clones through caspase activation, 2) determine
involvement of caspase-independent mechanisms in nsPEF-induced apoptosis in E4 cells
and Jurkat clones and 3) determine signaling pathways for caspase-dependent apoptosis
mediated by nsPEFs in E4 cells and Jurkat clones in vitro. Our findings are: 1) nsPEFs
appear to induce apoptosis through the extrinsic pathway in E4 cells because caspase
activation occurs before cytochrome c release. However, results from Jurkat clones,
which have mutations in the extrinsic apoptosis pathway, suggest that apoptosis is

induced by nsPEFs through the intrinsic pathway. 2) NsPEFs have rapid effects to
decrease the mitochondria membrane potential and in Jurkat cells this occurs in the
presence or absence of calcium or sodium. 3) NsPEFs activate calcium-dependent calpain
pathways in E4 cells, which, in part, contribute to Bid cleavage, with calcium
contributions from extracellular (70%) and intracellular (30%) compartments and 4) Cells
respond to nsPEFs differently in terms of caspase-dependent apoptotic pathways
depending on cell type. Apoptosis is induced through the intrinsic pathway in Jurkat
cells, whereas in E4 cells, both intrinsic and extrinsic pathways are activated upon
nsPEF-stimulation. These findings provide new insights into mechanisms by which
nsPEFs promote cancer cell death, and demonstrate that nsPEFs administration can be
utilized as a new therapeutic strategy for cancer ablation.
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1
CHAPTERI
INTRODUCTION

BACKGROUND
Apoptosis
Maintenance of homeostasis and development of multicellular eukaryotic
organisms require a delicate balance between cell division and cell death. Disturbance of
this balance has been implicated in diseases such as cancer due to pathological cell
accumulations. According to the nomenclature committee on cell death, four typical cell
death modalities and eight atypical cell death modalities has been recognized. Among the
best characterized modes of cell death are represented by apoptosis, autophagic cell
death, necrosis, and cornification (1). Necrosis has been considered a passive form of cell
death caused by catastrophic toxic or traumatic events. It is associated with swelling of
the cell and its organelles, cell lysis, release of cytoplasmic constituents and resulting
inflammation (2). Apoptosis, largely different from necrosis, is a genetically controlled
process of cell suicide that plays an important role in cellular homeostasis by eliminating
superfluous or damaged cells (3). Autophagic cell death is marked by the accumulation of
double- or multiple- membrane autophagosomes in the cytoplasm of cells. Cornification
represents the process of terminal keratinocyte differentiation, which allows the
formation of corneocytes in the epidermis. It is a particular form of programmed cell
death, morphologically and biochemically distinct from apoptosis (1).

The model of the Journal of Biological Chemistry is used in this dissertatioa
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Apoptosis is an evolutionaryy conserved suicide process that plays critical roles
in embryonic development, homeostasis, remodeling, surveillance and atrophy of normal
tissues (4). It can be induced in a vast array of ways such as nutrient exhaustion, ionizing
radiation, serum removal, growth factor deficiency (5-7). Apoptosis is a complex cascade
of events characterized by a series of morphological and biochemical alterations of the
cell including phosphatidyl serine (PS) externalization, mitochondrial cytochrome c
release, cell shrinkage, chromatin condensation, nucleosomal DNA fragmentation into
multiples of 180bp, and the disruption of mitochondrial membrane potential resulting in
plasma membrane blebbing and formation of apoptotic bodies. Finally, these apoptotic
bodies are engulfed and digested by neighboring cells or macrophages (8, 9). Activation
of caspases, a family of cysteine proteases, plays a central role in apoptosis. Apoptosis
can also occur through caspase-independent pathways (10).
Caspase
Caspases, or cysteine-aspartic proteases, are a family of cysteine proteases that
cleave substrates after aspartic acid residues. Caspases both initiate and execute cell
disassembly in response to pro-apoptotic signals. To date at least 14 distinct mammalian
caspases have been described in species ranging from the nematode to the dipteran
Drosophila melanogaster and the lepidopteran Spodoptera frugiperda (11). At least 8 of
the 14 caspases are involved in apoptosis and they are classified into two groups, the
initiator caspases, which include caspases-2, -8, -9 and -10, and executioner caspases,
which include caspases-3, -6, and -7.
All apoptotic caspases are present as inactive zymogens (pro-caspases) in cells
containing an N-terminal prodomain and a C-terminal catalytic domain consisting of ~20
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kD (p20) and -10 kD (plO) subdomains, and must undergo proteolytic cleavage to be
converted to activate forms during apoptosis (11). For all caspases, the main structures of
C-terminal domains share high sequence homology, while their N-terminal prodomains
differ dramatically. The initiator caspases usually contain large N-terminal domains, such
as the caspase recruitment domain (CARD) in caspase-2, -9, or a pair of death effecter
domains (DEDs) in caspase-8 and -10. These domains consist of specific protein-protein
interaction motifs that play crucial roles in the activation process (12).
Caspases are activated either by a ligand binding to death receptors that leads to
rapid induction of initiator caspases or by stimuli that release cytochrome c and apoptosis
inducing factors (AIF) from mitochondria. Upon apoptotic stimulation, the pro-caspase
are recruited by virtue of their N-terminal prodomain to specific death signaling
complexes and subsequently undergo self activation by "induced-proximity" mechanism
(13). In contrast, the executioner caspases only have short N-terminal domains and thus is
not capable of undergoing self activation in vivo. Their activation depends on the
cleavage of initiator caspases. The activating cleavage of executioner caspases is taken
place at specific internal Asp residues located in small linker regions between the
prodomain, p20, and plO subunits by an initiator caspase (11). This separation of the
large and small subunits allows two p20 and two plO subunits to resemble noncovalently
into the active executioner caspase.
Once activated, the executioner caspases cleave a broad range of cellular targets
and ultimately destruct the cell. The known cellular substrates include structural
components (such as actin and nuclear lamin), poly (ADP-ribose) polymerase (PARP),
inhibitors of deoxyribonuclease (such as DFF45 or ICAD), and other pro-apoptotic

4

proteins and caspases. Cleavage of the DFF45 (DNA fragmentation factor 45) leads to
removal of its inhibition of DFF45 or CAD (caspases-activated deoxyribonuclease),
which degrades the chromosomes into nucleosomal fragments during apoptosis (14).
Apoptosis pathways
Extrinsic pathway
Apoptosis can be mediated through the extrinsic pathway or the intrinsic pathway
depending on the cell type and the origin of the death stimuli. The extrinsic pathway is
initiated by the recruitment of the tumor necrosis factor (TNF) receptor super-family such
as CD95 (APO-1/Fas) or TNF-related apoptosis-inducing ligand (TRAIL) receptors and
specific death ligands, which then assemble the death-inducing signaling complex
(DISC) and leads to proteolytic cleavage and activation of caspase-8. In type I cells,
caspase 8 directly cleaves downstream executioner caspase-3, -6, and -7 and mediates
cell death. Whereas in type II pathways, caspase-8 cleaves the BH3 domain-containing
pro-apoptotic protein Bid. Translocation of truncated form of Bid in collaboration with
Bax or Bak triggers the release of pro-apoptotic proteins from the mitochondrial
intermembrane space, including cytochrome c, apoptosis-inducing factor (AIF), and
second mitochondrial-derived activator of caspase (Smac/DIABLO). Once cytochrome c
is released into cytosol, it interacts with apoptotic protease-activating factor-1 (Apaf-1)
and enables the assembly of the apoptosome, in which caspase-9 is autoproteolytically
activated. Caspase-9 then activates executioner caspase-3, -6, -7, and promotes further
activation of the initiator caspase-8 and -10 as a positive feedback loop in the extrinsic
pathway (15). Smac/DIABLO activates caspase-9 and -3 by neutralizing the inhibitory
effect of IAP (inhibitors of apoptosis proteins) through physical interactions (16, 17).
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Death receptor
The most direct pathway connecting death-promoting signals to apoptotic cell
demise to be mediated by the death receptors, such as the type 1 tumor necrosis factor a
(TNFa) receptor TNF-R1 (CD 120a), CD95 (Fas/APO-1), DR3 (TRAMP/wsl/APO-3),
TRAIL-R1 (DR4), TRAIL-R2 (DR5), a subgroup of the TNF-R superfamily, and their
cognate death ligands TNFa, CD95 ligand (FasL), Apo3L and TRAIL (APO-2L),
respectively (18-21). Binding of a ligand to its cell-surface death receptor facilitates
receptor aggregation and recruitment of pro-apoptotic adaptor molecules such as TRADD
(Tumor necrosis factor receptor type 1-associated DEATH domain protein) and FADD
(Fas-associated via death domain) through homotypic interactions between death
domains (DD) in each of the protein (22). In turn, adaptors associated with caspase-8
(FLICE) through the death-effector domains (DED) in a homotypic manner resulting in
the formation of a DISC (23). Within the complex, caspase-8 is dimerization and
proteolytically activated. This in turn activates terminal executioner caspases either via
direct activation of executioner caspases (type I cells) or through activation of the
mitochondrial pro-apoptotic machinery (type II cells) (24). Inhibition of death receptorinduced apoptosis may occur at the DISC level resulting from binding of FLIPs (FLICEinhibitory proteins) to FADD or mitochondrial level due to high levels of Bcl-2 or Bcl-xl
(25).
Intrinsic pathway
The intrinsic pathway is activated by a wide range of internal stresses, such as
oxidative stress, DNA double strand break, misfolded protein in endoplasmic reticulum
and oncogenes activation. All of these stimuli cause changes in the inner mitochondrial
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membrane that result in an opening of the mitochondrial permeability transition pore
(mPTP), loss of the mitochondrial transmembrane potential and release of two main
groups of pro-apoptotic proteins from the intermembrane space into the cytosol (26). The
first group of well-characterized proteins include cytochrome c, Smac/DIABLO, and
HtrA2/Omi (17, 27). These proteins trigger apoptosis through the caspases-dependent
mitochondrial pathway. Cytochrome c binds to Apaf-1 (apoptotic protease-activating
factor 1), inducing Apaf-1 to undergo a nucleotide d ATP-dependent conformational
change which forms a multiprotein caspases-activating complex, "apoptosome" and
facilitates binding of pro-caspase 9 through N-terminal CARD domains present in both
molecules (28). As a result of this binding, pro-caspase 9 is activated. Smac/DIABLO
and HtrA2/Omi are reported to block caspse inhibitory activity of IAP (inhibitors of
apoptosis proteins) (16, 17). The cleavage of their mitochondrial-targeting sequences
generates the IAP-binding motif, which contains a conserved short stretch of hydrophobic
amino acids, AVPI or AVPS, in Smac and Omi, respectively. This motif is exposed upon
release into the cytosol leading to Smac and Omi binds to the BIR domains of IAP and
hence the BIR-bound caspases are released and reactivated (29).
It has now been recognized that the second group of pro-apoptotic factors released
from the mitochondria during apoptosis consists of AIF, EndoG (endonuclease G), that
are involved in caspases-independent cell death (30, 31). AIF translocates to the nucleus
and subsequently initiates a type of peripheral nuclear chromatin condensation and largescale (50kb) DNA fragmentation (32). It has been reported that, in mammalian cells,
EndoG also translocates to the nucleus during apoptosis where it induces
oligonucleosomal DNA fragmentation independent of caspases (33). Moreover,
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subsequent studies have demonstrated that EndoG can cooperate with exonuclease and
DNase and facilitate both high molecular weight DNA cleavage and oligonucleosomal
DNA breakdown in a sequential fashion.
Bcl-2 family and cytochrome c release
Bcl-2 family proteins and play a pivotal role in controlling and regulating these
apoptotic mitochondrial events through governing the permeability of the outer
mitochondrial membrane (34). To date, at least 20 Bcl-2 family members have been
identified in mammalian cells and viruses, exhibiting either proapoptotic or antiapoptotic
properties (35). Bcl-2 and Bcl-xl are antiapoptotic members. They protect cells against
apoptosis by inhibiting the function of the pro-apoptotic Bcl-2 proteins. The cleavage of
Bcl-2 and Bcl-xl by caspases reinforces cytochrome c release from the mitochondria (36).
The proapoptotic members can be divided into two subfamilies based on structure
discrepancies. Bax and Bak share three BH domains and lack the BH4 domain. The
proapoptotic protein Bax is localized in the cytosol and translocates to mitochondria upon
apoptotic stimulation (37). Unlike Bax, Bak constitutively resides on mitochondria and
homo-oligomerizes during apoptosis (38). In the mitochondrial outer membrane, the
proapoptotic functions of Bak and the related Bax protein depend at least in part on the
presence of Bid. Bid is a BH3-domain-only proapoptotic protein which usually resides in
an inactive form in the cytosol. After activation of Fas/Fas-L or TNF receptor pathway,
the amino-terminal portion of Bid is cleaved, the COOH-terminal part of Bid translocates
onto mitochondria and induces the oligomerization of Bak and Bax into large complexes,
which forms ion channels in the outer mitochondrial membrane and allows exit of
cytochrome c (39). Cleavage of Bid to the active, truncated form, t-Bid, is a feature of
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caspase-8-mediated apoptosis induced via death receptors (40). It has been shown that
caspase-8 cleave Bid after Asp59 in some cell lines, thereby changing Bid from a
potential to a strongly pro-apoptotic molecule, capable of inducing cytochrome c release
and subsequent activation of caspase-9 (41). Bid is also cleaved during apoptosis by
caspase-3 in the intrinsic pathway to apoptosis, which is independent of death receptors
(42); by granzyme B (43); by calpains between Gly70 and Arg71 (44); and by lysosomal
proteases (45).
The precise mechanism of cytochrome c liberation from mitochondria remains
elusive, and observations have varied with different cell types and stimulus signals (46).
It has been proposed that a distinct two-step process is involved in cytochrome c release,
including disassociation of cytochrome c with its membrane anchor cardiolipin and
permeabilization of mitochondrial outer membrane by Bax insertion such that disruption
of A\|im and subsequent ATP depletion compromises cytochrome c release (47).
Cardiolipin is an anionic phospholipid which is present predominantly in the inner
mitochondrial membrane. It has been indicated that the disruption of the cytochrome ccardiolipin interaction is a crucial initial step for the release of cytochrome c into the
extra-mitochondrial milieu and for the induction of apoptosis. The peroxidation of
cardiolipin causes the binding affinity for cytochrome c, a heme protein to decrease,
which facilitate the detachment of cytochrome c (47). In addition, Ca2+ can bind to and
induce a conformational change in cardiolipin that can lead to an increase in reactive
oxygen species (ROS) by the respiration chain, which promotes the oxidation of
membrane and therefore increase in membrane permeability.
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Puma (p53-upregulated modifier of apoptosis) and Noxa also belong to the
proapoptotic BH3-only group of the Bcl-2 family, are well-known direct transcriptional
targets of p53 (48, 49). They might be involved in mediation of apoptosis that is induced
by genotoxic damage or oncogene activation. It was shown that Noxa can undergo BH3
motif-dependent localization to the mitochondria and interact with anti-apoptotic Bcl-2
family members Bcl-2 and Bcl-xl, leading to cytochrome c release and the activation of
caspase-9 (49). Puma is an important mediator of p53-induced apoptosis. Studies show
that Puma expression promotes conformational change and mitochondrial translocation
of Bax, cytochrome c release and reduction in the mitochondrial membrane potential (50).
The affinity of p53 and Bax binding is weak in contrast to p53 and Puma binding, thus
Bax participates indirectly in the death response of p53 through Puma (48).
p53 also possesses a transcription-independent proapoptotic function that directly
activating the Bax or Bak (51). The Bax/Bak then promotes mitochondrial outer
membrane permeabilization (MOMP) (52). Once MOMP occurs, pro-apopto genie factors
are released, culminating in apoptosis induction rapidly.
Mitochondrial membrane potential (A\ym) in apoptosis
The relationship between A\|/m dissipation and apoptosis induction is still
uncertain. Evidences demonstrate that mitochondrial structure changes and A\|/m
disruption are early requirements in some regimes of induction of apoptosis. The SV40
large T antigen induced early A\|/m drop in rat embryo cells undergoing apoptosis (53).
Human peripheral blood mononuclear induced to undergo apoptosis by dexamethasone
show a decrease in 3,3' dihexyloxacarbocyanine iodide (DiOCe) uptake prior to
appearance of any morphological signs of apoptosis (54). Also, thymocytes treated with
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dexamethasone showed both an early decrease in Aym as examined by 5,5',6,6'tetrachloro-l,l',3,3'-tetraethyl benzimidazolylcarbocyannine iodide (JC-1), and
mitochondrial structure change (55).
Early loss of A\|/m may occur though caspase-independent mechanisms. Jurkat,
JMI and U937 cells induced to undergo apoptosis by the nucleoside analogue 2-chloro2'-deoxyadenosine, showed A\|/m decrease preceded detectable caspase activation.
Furthermore, caspase inhibitor z-VAD-fmk inhibited cell death without preventing A\|/m
dissipation (56).
Ca2+ has been known to be a key molecule responsible for mPTP opening. The
opening of mPTP leads to mitochondrial permeability transition (mPT), a sudden increase
in permeability of the inner mitochondrial membrane to solutes with a molecular mass
less than 1.5 kD and some proteins. The opening of mPTP causes disruption of A\|/m (57).
The mPT causes disruption of A\|/m. The apoptosis stimuli which induce cytosolic Ca
level elevation can trigger early A\|/m decrease prior to caspase activation (58).
Intracellular calcium chelators can lower the calcium concentration to below the mPTP
activation threshold and therefore blocking apoptosis signaling pathways.
However, accumulating data also indicate that there is no early requirement for
A\|/m loss for apoptosis; A\|/m decrease can be a consequence of apoptosis induction. HL60 cells induced to undergo apoptosis by actinomycin-D, etoposide, or staurosporine
showed detectable A\|/m loss occurred concurrently with cytochrome c release, caspase
activation, and DNA fragmentation as a late event during the apoptosis process (59).
Epidermal keratinocytes treated with UV radiation have been reported to undergo
apoptosis DNA damage within minutes of treatment, and caspases-3 cleavage of protein
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kinase C delta (PKC8) allows it to translocate to the mitochondrial where it causes the
loss of A\|/m several hours later (60). Similar findings have been reported in L929
fibroblast treated with etoposide, five distinct biochemical events have been shown to
occur with A\|/m collapse as a late event, following nuclear alterations (p53
phosphorylation) and Bax translocation to the mitochondria (61).
In conclusion, the role of mitochondrial membrane depolarization in apoptosis is
still controversial. It raises the possibility that A\|/m decrease may be a subsequent event
of apoptosis and may serve as an amplifying mechanism for apoptosis processes.
Involvement of mitochondria membrane potential (Ay/m) in cytochrome c release
The concept of mPTP opening permits the translocation of several mitochondrial
proapoptotic proteins during apoptosis has emerged recently (62). However, the
mechanism of how the mPTP results in these proapoptotic factors release is still unknown
(63). The molecular composition of mPTP has not yet been fully identified. It has been
proposed that mPTP consist of the outer membrane voltage-dependent anion channel
(VDAC), an inner membrane protein adenine nucleotide translocator (ANT), and a
matrix protein cyclophilin D (CypD). Several other proteins such as peripheral
benzodiazepine receptors (PBR), creatine kinase (CK), hexokinase and Bcl-2 family
members (Bcl-2, Bcl-xl, and Bax) are proposed to be involved in the regulation of mPTP
activity (64). Both the A\|/m and the pH of the mitochondrial matrix operate mPTP
opening. The decrease in A\|/m promotes mPTP open whereas the acidification of the
mitochondrial matrix decrease the probability of pore opening (65).
It remains uncertain whether the loss of A\|/m is actually necessary for cytochrome
c release to occur. In some cell systems, the mPT is associates with cytochrome c release.
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In rat hepatocytes, which were induced to undergo apoptosis in response to microcystinLR, mPT and subsequent drop in Aym played important roles in cytochrome c release. It
was shown that cytochrome c release can be inhibited by a specific mPT inhibitor
(cyclosporin A, CsA), and by various mitochondrial electron transport chain inhibitors
(66). The decrease in A\|/m which was documented by tetramethylrhodamine methyl ester
(TMRE) was recorded to coincide with the release of transfected green fluorescent
protein (GFP)-tagged cytochrome c after staurosporine treatment in pheochromocytoma6 cells (67).
However, some data indicate that mPT and cytochrome c are not strictly
correlated. In etoposide or N-tosyl-L-phenylalanyl chloromethyl ketone inducedapoptosis in human monocytic THP.l cells, cytochrome c release was reported to occur
before mitochondrial membrane potential depolarized and obvious rupture of the outer
mitochondrial membrane (68). Also, a BH3 death domain peptide corresponding to
amino acids 53-58 of Bax caused cytochrome c release independent of mPT and A\|/m
disruption, and therefore without affecting the integrity of inner mitochondrial membrane
(69). Similarly, it has been shown that the BH3-only Bcl-2 family proteins Bid and Bik
induce cytochorome c release in a Ca2+-independent manner without A\|/m loss (70, 71).
Execution pathway
The extrinsic and intrinsic pathways converge to the point of the executioner
caspases, caspase-3, caspase-6, and caspase-7. Activation of these caspases is considered
the final point-of-no-return phase of apoptosis, the cell will be destroyed ultimately once
executioner caspases are activated. Executioner caspases activate cytoplasmic
endonucleases and proteases that degrade and cleave various nuclear and cytoskeletal
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substrates including cytokeratins, poly (ADP-ribose) polymerase PARP, the plasma
membrane cytoskeletal protein alpha fodrin, the nuclear matrix protein NuMA and
others, resulting in widespread morphological and biochemical changes to the cell (72).
Caspase-3 is the most important executioner caspase and can be activated by any of the
initiator caspases (caspase-8, caspase-9, or caspase-10). Caspase-3 specifically activates
the endonuclease CAD responsible for DNA fragmentation at the linker region between
nucleosomes. In proliferating cells CAD exists as a complex with its inhibitor (ICAD)
and its DNase activity is suppressed. In apoptotic cells, activated caspase-3 cleaves ICAD
to release CAD from CAD-ICAD complex, allowing CAD to cleave chromosomal DNA
within the nuclei (73). Caspase-3 also induces cytoskeletal reorganization and
disintegration of the cell into apoptotic bodies.
These mechanisms represent simplified pathways without including extremely
complicated interactions between caspases and other regulatory molecules. For example,
caspase-3 can activate pro-caspase-9 (74). Likewise, caspase-6 can activate caspase-3
(75). Caspase-3 can also be activated via a feedback loop involving the mitochondria,
amplifying the caspases signal that commits the cell to the death pathway inevitably, but
how this occurs remains to be elucidated.
Phosphorylation ofH2AX
DNA damage plays a major role in human pathology. There are a number of
exogenous and endogenous factors are known to induce DNA damage, such as UV
radiation, ionizing radiations (X-rays, y-rays, alpha particles), acridine dye, mustard gas,
bleomycin, and metabolic process. Acridine dye induce deletion and insertion of single
base pair in DNA helix (76). Damaged DNA replication forks or from oxidative
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destruction of deoxyribose residues may also cause DNA breaks. DNA double-strand
breaks (DSBs) are a type of DNA damage in which two single-strand nicks in the
complementary double helix of DNA occurs simultaneously and sufficiently close to one
another in locations, typically within 10-20 base pairs (77). The DSBs is the most lethal
form of DNA damage that can initiate genomic instability and promote tumorigenesis.
Many factors such as ionizing radiation and genotoxic drugs may induce DSB formation.
An early event response to DSBs is the rapid phosphorylation of a histone H2A variant,
denoted as H2AX, in the position of Ser-139 to form yH2AX (78). This phosphorylation
event is by far the most studied chromatin modifications linked to DNA damage and
repair.
Serine 139 in the distinct carboxy-terminal extension of H2AX is phosphorylated
by several members of the phophoinositide 3-kinase-related protein kinase (PIKKs) such
as ATM (ataxia teleangiectasia mutated), ATR (ATM and Rad3-related), or DNAdependent protein kinase (DNA-PK) within 1 to 3 minutes after DSBs generation, and the
number of phosphorylated H2AX molecules is proportional to the severity of the DNA
damage. ATM kinase is a main physiological mediator of H2AX phosphorylation after
introduction of DSBs (79). ATM is activated by rapid intermolecular
autophosphorylation of Serl981, which leads to dissociation of the inactive ATM dimers
into single protein molecules and initiates ATM kinase activity (79). ATR mediates
H2AX phosphorylation in cells triggered by the formation of single-stranded DNA
(ssDNA) and the accumulation of repair intermediates (80). Phosphorylation of H2AX by
DNA-PK has been shown to occur during apoptotic DNA fragmentation (81), and is
responsible for the enhanced phosphorylation of H2AX under hypertonic conditions (82).
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At the sites of DSBs, yH2AX appears to have a important function in the
accumulation of DNA damage signaling and recruitment of DNA damage response
(DDR) proteins such as MRE11/NBS1/RAD50, MDC1, 53BP1, and BRCA1 to nuclear
foci where these proteins interact with yH2AX (83). Moreover, yH2AX promotes
chromatin remodeling by providing a docking site for protein complex to prevent
dissociation of break ends and enhance DSBs repair efficiency (84).
Calpain activation
In addition to caspase-dependent programmed cell death (PCD), caspaseindependent PCD involves activation of other proteases, e.g., calpain and cathepsins.
They can be governed by several cellular organelles independently or collaboratively,
including mitochondria, lysosomes, and the endoplasmic reticulum (ER). Lysosomes can
cause cellular damage through the release of digestive enzymes. Two lysosomal proteins,
cathepsin B and D, translocate to the cytosol during PCD, and can become the
dominatnexecution protease in PCD (85). Cathepsins have also been involved in Bid
cleavage in the process of caspases activation (45).
Calpains are a family of intracellular calcium-dependent cysteine proteases, which
can be divided into ubiquitous, tissue-specific and atypical calpains (86). Ubiquitous
calpains have two isozyme forms; u-calpain (calpain I) and m-calpain (calpain II) that are
require micromolar or millimolar calcium concentrations for their activation in vitro,
respectively (87, 88). The active isozymes consist of a common 30 kD regulatory subunit
and a unique 80 kD catalytic subunit (89).
Calcium-activated calpain have many substrate proteins which can directly or
indirectly lead to cell death upon cleavage. In vitro substrates for calpain include
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cytoskeletal proteins, kinases and phosphatases, growth factor receptors, transcription
receptors, integral membrane proteins, ion channels and signal-transducing enzymes (90,
91)."
There are several common proteins that can be cleaved by both calpains and
caspases, such as caspases themselves (pro-caspase-3/-7, -8, -9, and -12), Bcl-2 family
proteins (Bax, Bcl-2, Bcl-xl and Bid), signal transduction protein (PKC-a and PKC-5)
and DNA-repair and cell-cycle regulatory proteins (PARP, cyclin D and p53), indicating
that there is crosstalk between calpains and caspases in the modulation of cell death (9295). Calpain may induce apoptosis through mitochondrial pathways by cleaving Bax and
Bid (92, 96), which in turn trigger the release of pro-apoptotic proteins and downstream
caspase-dependent (cytochrome c and Smac/DIABLO) or caspase-independent (AIF and
Endo G) pathways. The fragments of Bax cleavage by calpain is a more potent apoptosis
inducer than uncleaved Bax (97). Similarly, the BH3 domain of Bid remain intact after
calpain cleaves between Gly70 and Arg71, thus the pro-apoptotic activity of Bid is
maintained (98). Calpain promotes the intrinsic apoptotic pathway via Bcl-2 inactivation
in LCLC 103H lung carcinoma cells treated with the calcium ionophore ionomycin (99).
It is also shown that calpain is able to mediate Bid cleavage in cisplatin-induced
apoptosis, which is important in chemotherapy agent triggered cell death (44). Also,
calpain is involved in Bid cleavage mechanisms in nsPEF-induced cell death in E4
squamous cell carcinoma (SCC) in vitro (100). Furthermore, calpain activation
subsequent to an elevation of intracellular Ca released from mitochondria has been
shown to cause apoptosis without the activation of caspase-3 and caspase-9 in rat
hepatocytes treated with microcystin-LR (MLR), a specific hepatotoxin (66). Although
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calpain has been reported to play an active role in apoptosis-related signaling pathways,
compared to caspases, only little is known about the precise roles of calpain in apoptosis.
Nanosecond pulsed electric fields (nsPEFs) and cell death
Utilizing nsPEFs has been shown to be a new method of activating apoptosis
signaling pathways (101, 102). NsPEFs are non-ionizing electric fields which are
characterized by ultrashort duration (nanosecond range), high power (megawatts), low
energy density (mJ/cc) and non-thermal (103). Comparing to conventional
electroporation pulses, which is used to create transient pores in plasma membrane for
introducing large molecules into the cells by the application of a short (|o,s to ms) electric
field pulse, nsPEFs have effects on both plasma membrane and intracellular membranes
(104).
It has been shown that nanosecond pulses with duration shorter than the charging
time of the outer cell membrane (100 ns) and high electric field amplitudes can allow
access to the cell interior and physically manipulating intracellular cell structures and
functions without irreversibly porating the plasma membrane.
Experimental results have indicated that nsPEFs affect plasma membrane
structure, including invoking the loss of phosphatidylserine (PS) asymmetry (101) and
facilitating the uptake of dyes such as propidium iodide (PI) or ethidium homodime (105,
106). Accumulating results indicate that nsPEFs might manipulate intracellular
mechanisms through plasma membrane. Hallmarks of apoptosis, such as PS
externalization, caspase activation, cytochrome c release and DNA fragmentation have
been observed after nsPEFs exposure. Other applications of nsPEFs are also shown to
trigger the release of intracellular calcium from internal stores (107-109), permit sodium
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entry into the cell (108), promote human platelets aggregation (110), induce action
potentials in cardiac myocytes (111), induce calpain activation (100) and completely
eliminate B16fl0 murine melanoma without recurrence in vivo (112-114). However, in
this dissertation, apoptosis induction is a primary motive.
Apoptosis has been observed in human Jurkat, HCT116 and HL-60 cells in vitro
exposed to pulses of 10-300 ns, and up to 300 kV/cm (101, 107, 115, 116). It is indicated
that apoptosis was initiated upon the electric field amplitude exceeding the threshold,
which varies depending on cell types. Apoptosis markers, such as caspases activation and
cytochrome c release can be detected in a relatively short time frame (tens of minutes)
following nsPEF-treatment. While Annexin-V binding is often used as an apoptosis
marker, it is not recommended as an apoptosis marker when in response to nsPEFs, since
the electric fields can result in externalization of PS as a direct effects (117).
However, the molecular and cellular mechanisms leading to apoptosis after
nsPEFs treatment remain obscure. It appears most likely that electroporative
permeabilization of organelles leads to the translocation of pro-apoptotic factors, such as
cytochrome c or AIF, from mitochondria to cytosol, ultimately resulting in the execution
of cell death (53, 118).
An increase in mitochondrial outer membrane permeability is a crucial step in
apoptotic cell death. This event allows the release of mitochondrial death factors, which
facilitate different signaling cascades and eventually cause cell death. The mPTP has
been known as one of the major players in this process. The opening of mPTP leads to
solutes (K+, Ma2+ and Ca2+ ions) and water enter the mitochondria, mitochondrial matrix
swelling and outer membrane rupture and a subsequent nonspecific release of
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proapoptotic proteins from the intermembrane space into the cytosol (119). Weaver et al.
hypothesized that mitochondrial membrane electroporation due to very large magnitude
ultrashort pulse could cause mitochondrial transmembrane voltage change, which bring
about the opening of the mPTP and hence induction of apoptosis (120).
The initiation of extensive calcium release is considered to be another candidate
mechanism for nsPEF-induced apoptosis. It was found that, in experiments on E4 mouse
SCC, chelating intracellular and (or) extracellular calcium with BAPTA and EGTA
inhibited Bid cleavage and t-Bid generation, which is believed to be the interconnection
between intrinsic pathway and extrinsic pathway (100). However, experimental studies,
in which Jurkat human T lymphocyte cells, HL-60 human promyelocytic leukemia cells
and B16fl0 mouse melanoma cells were exposed to nsPEFs in the presence of EGTA and
BAPTA, have shown that calcium had relatively little or no impact on caspase activation,
though calcium clearly plays a role in other aspects of apoptosis (105).
NsPEFs and cancer treatment
Electrical pulses have been introduced to cancer treatment since 1980s, where
short, high voltage pulses are usually used to transiently permeabilize the cell membrane
and facilitate the delivery of lipophilic chemicals, such as bleomycin, cis- and
carboplatinum. This approach is called electrochemotherapy (ECT) (121). ECT employs
reversible electroporation pulses (typically a sequence of eight 100 ms pulses of
approximately 1000 V/cm) to reversibly facilitate the penetration into cells of small
amounts of drugs, gene materials, proteins and other large molecules. Although the
application of ECT greatly enhances the cytotoxicity of chemotherapeutic drugs, it still
cannot completely avoid deleterious side effects.
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The inactivation of apoptotic machinery, which gives rise to excessive
proliferation and dysregulated accumulation of tissue mass, is generally regarded as a
hallmark in the development and progression of cancer (122). The ability of cancer cells
to evade apoptotic mechanisms can play a significant role in the resistance to
conventional therapeutic regimens. Thus, exploiting apoptosis as a further therapeutic
strategy to trigger tumor-selective cell death without compromising normal cell function
are of importance.
Necrosis, characterized by plasma membrane rupture, always accompany with
inflammatory response and detrimental effect to surrounding cells and tissues. In contrast
to necrosis, apoptosis is considered as "cell suicide". It is associated with rapid removal
of cell corpses by phagocytic cell that recognize "eat-me" signals on the outer membrane
of the apoptotic cells (8, 9). This makes apoptosis a desirable target mechanism for
cancer treatment. Furthermore, apoptosis mechanisms are frequently altered in cancer
cells. It provides the opportunity for selectively killing of cancer cells without affecting
normal cells.
Accumulating experimental results has demonstrated the effectiveness of nsPEFs
on elimination of cancer cells. In vivo experiment showed a significant apoptosis with
reduced tumor size and weight in B10.2 mouse fibrosarcoma tumors after treatment with
nsPEFs (123). Nuccitelli et al. found that pulsed electric fields greater than 20 kV/cm
with rise times of 30 ns and durations of 300 ns caused tumor cell nuclei to rapidly shrink
and ceased blood flow to the tumor (113). Furthermore, a long-term in vivo study showed
that both necrosis and apoptosis were triggered in murine melanoma with application of
300, 40 kV/cm, 300 ns electrical pulses. Complete tumor remission without recurrence
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was found within 180 days after treatment (112). A most recent result indicated that
murine skin melanomas could be eliminated with an optimized single treatment using the
pulse parameters (2,000 pulses, 100 ns in duration, 30 kV/cm in amplitude at a pulse
frequency of 5-7 pulses/sec) (124). It has been reported that melanoma shrinkage is
associated with activation of executioner caspases, which remain active 2-8 hours after
treatment, indicating apoptosis is induced by nsPEFs in melanoma in vivo (114). Recent
unpublished studies indicated that mouse hepatoma (Hepa 1-6) that were exposed to
nsPEFs ex vivo and in vivo exhibit DNA fragmentation, elevated caspase activity, and
shrank tumor size (Chen et al, submitted).
Furthermore, nsPEFs can affect cancer metastasis and angiogenesis. It was found
that nsPEFs could reduce the possibility of lymphatic metastasis by destructing lymphatic
capillaries around cancer (125). Reduction in blood flow was detected after nsPEFtreatment (113). Several molecular indicators for anti-angiogenesis, such as decreased
vessel numbers, vascular endothelial growth factor (VEGF), platelet derived endothelial
cell growth factor (PD-ECGF), CD31, CD35 and CD 105 were found within one week of
electric field application (114).
SPECIFIC AIMS
Apoptosis is the most common physiological mechanism by which the organism
eliminates unwanted cells. Apoptosis plays a crucial role in embryogenesis, tissue
remodeling, immune regulation, cellular homeostasis and tumor regression. Several
studies showed that nsPEFs induce cell death in a variety of cancer cells and tumors.
However, the cellular and molecular mechanisms underlying nsPEF-induced apoptosis
are still unclear. My overall goal is to gain greater insight into nsPEFs-induced cell death
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mechanisms including apoptosis in cutaneous cancer cell lines and selective Jurkat cell
clones as a necessary prerequisite to the development of nsPEFs as a novel anticancer
treatment. The hypothesis is that nsPEFs can induce apoptosis, and mechanisms are not
limited to caspase-dependent pathways; activation of caspase-independent mechanisms
that cross-talk with caspase-dependent mechanisms are also involved. The specific
hypothesis behind these studies is that nsPEFs eliminate cancer cells through activating
multiple apoptosis pathways in a cell type-dependent manner. Successful realization of
these aims will provide a comprehensive assessment of nsPEF mechanisms to eliminate
cancer cells. Based on results from in vitro and in vivo melanoma studies (105, 114),
these in vitro results obtained here should translate to tumor cells in vivo.

The Specific Aims of this dissertation are as follows:

Specific Aim 1: To determine whether nsPEFs induce cell death in E4 cells and Jurkat
cells (wildtype, FADD deficient, caspase-8 deficient clones) through apoptosis.
Specific Aim 2: To determine involvement of caspase-independent mechanisms in
nsPEF-induced apoptosis in E4 cells and Jurkat clones in vitro
Specific Aim 3: To determine the signaling pathways for caspase-dependent apoptosis
mediated by nsPEFs in E4 cells and Jurkat clones in vitro
SIGNIFICANCE
Cancer is the second leading cause of death in America, accounting for
approximately 23% of all deaths (126). Until now, cancer is still difficult to treat in spite
of many treatment modalities. There are additional barriers within solid tumors that
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hinder penetration of drugs to heterogeneous and irregularly vascularized tumor tissue
and thereby failing to reach therapeutic levels within all the cancer cells (127, 128).
Accordingly, local therapies that kill all cancer cells by inducing apoptotic machinery
within a selected tissue area are of great interest, especially when they can be detected
and treated early.
The application of nsPEFs has been shown to be an effective localized low-energy
treatment without the additional requirement of chemotherapeutic agents and obvious
inflammatory response at the treatment site (129). Better understanding of the molecular
mechanism(s) of nsPEF-induced cell death will advance the development of this targeted
strategy to be a novel way for the treatment of cancer.
Defects in apoptosis are considered to be a major hallmark of cancer, and
contribute to drug resistance and recurrences of cancer therapy (122). One of the ultimate
therapeutic goals in cancer treatment is to trigger apoptotic machinery in cancer cells to
induce their suicide. Thus, direct initiation of cancer cell apoptosis mechanisms
constitutes an appealing approach for the treatment of cancer.
Once death receptors and mitochondria pathways are activated, these death
receptors and proteins released from mitochondria trigger apoptosis signaling and, hence,
they can regulate cell death. By modulating apoptosis machinery of cancer cells, nsPEFs
should be capable of enforcing cancer cells' own cell death. Since alterations of apoptosis
mechanisms invariably accompany tumorigenesis, unraveling nsPEFs-induced apoptosis
mechanisms could help design nsPEFs as a new therapeutic approach for treating cancer.
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CHAPTER II
AN APOPTOSIS TARGETED STIMULUS WITH NANOSECOND PULSED
ELECTRIC FIELDS (NSPEFS) IN E4 SQUAMOUS CELL CARCINOMA

ABSTRACT
Stimuli directed towards activation of apoptosis mechanisms are an attractive
approach to eliminate evasion of apoptosis, a ubiquitous cancer hallmark. In these in vitro
studies, kinetics and electric field thresholds for several apoptosis characteristics are
defined in E4 SCC exposed to ten 300 ns pulses with increasing electric fields. Cell death
was >95% at the highest electric field and coincident with phosphatidylserine
externalization, caspase and calpain activation in the presence and absence of cytochrome
c release, decreases in Bid and mitochondria membrane potential (A\|/m) without apparent
changes reactive oxygen species levels or in Bcl-2 and Bcl-xl levels. Bid cleavage was
caspase-dependent (55-60%) and calcium-dependent (40-45%). Intracellular calcium as
an intrinsic mechanism and extracellular calcium as an extrinsic mechanism were
responsible for about 30 and 70% of calcium dependence for Bid cleavage, respectively.
The results reveal electric field-mediated cell death induction and progression, activating
pro-apoptotic like mechanisms and affecting plasma membrane and intracellular
functions, primarily through extrinsic-like pathways with smaller contributions from
intrinsic-like pathways. NsPEFs trigger heterogeneous cell death mechanisms in E4 SCC
populations to delete them, with caspase-associated cell death as a predominant, but not
an unaccompanied event.
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INTRODUCTION
The administration of nsPEFs is emerging as a novel stimulus for inducing cell
death. Apoptosis can be activated by nsPEFs in various cancer cell lines in vitro (101,
105, 115), a fibrosarcoma tumor ex vivo (101, 107, 123, 130) and in B16fl0 melanoma
tumors in vivo (114). Apoptosis is a highly conserved mechanism in eukaryotes for
eliminating superfluous, aberrant and damaged cells. It is a complex cascade of events
morphologically characterized by phosphatidylserine externalization, cell shrinkage,
chromatin condensation, nucleosomal DNA fragmentation, disruption of mitochondrial
membrane potential (A\|/m) resulting in plasma membrane blebbing and formation of
apoptotic bodies (131). These morphological features are believed to be caused at least in
part by activation of caspases, a family of cysteine proteases, which plays a crucial role to
initiate and execute apoptosis (9, 132, 133), although other proteases may also be
activated.
Caspases can be triggered through extrinsic death receptor pathways or intrinsic
pathways depending on the cell type and stimulus (1, 134). Extrinsic pathway are
initiated by specific ligands, such as Fas and TRAIL, which aggregate their cognate death
receptor, allowing assembly of death-inducing signaling complexes (DISC) on the
cytoplasmic side of plasma membranes leading to initiator caspase-8 (and/or -10)
activation. In type I cells, caspase-8 activates executioner caspases independent of
mitochondria. Whereas, is type II cells, Bid was cleaved to pro-apoptotic truncated Bid
(t-Bid). Translocation oft-Bid triggers cytochrome c release from mitochondria and
caspase-9 activation through formation of the apoptosome, which causes cell demise
through activation of caspase-3.
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Unlike conventional electroporation, which primarily affects plasma membranes
(135, 136), nsPEFs also electroporate intracellular membranes (104). Modeling studies
(135-138) and evidence determined experimentally by patch clamp and fluorescent
imaging studies (139, 140), indicated that nsPEFs with sufficiently short pulse durations
and rapid rise times (104) induced nanopores in plasma membranes that were often
smaller than propidium iodide (PI). This supra-electroporation involved all cell
membranes going through cells, extensively penetrating all organellar membranes (135,
136). Effects on intracellular vesicles were observed without measurable effects on
plasma membranes (104, 141) with PI or calcein and on intracellular calcium
mobilization from the endoplasmic reticulum and capacitative calcium entry in HL-60
cells (109), suggesting that these external electric fields can mimic ligand signaling (107).
It is now know that the absence of effects on plasma membranes was due to the presence
of nanopores that were too small to allow entry of the membrane markers or that
detection systems were insufficiently sensitive to measure them (139, 140). Nevertheless,
modeling evidence suggests that under certain circumstances it is possible to have effects
on intracellular membranes without effects on the plasma membrane (138).
Studies have suggested that nsPEF-induced apoptosis mechanisms are cell typedependent. In Jurkat cells caspase activation and cytochrome c release were nearly
coincident, making it difficult to differentiate between extrinsic and intrinsic mechanisms
(101). In B16fl0 cells cytochrome c was not released, implicating the extrinsic apoptosis
pathway typical of type I cells (105). In HCT 116 cells, caspase activation occurred
before cytochrome c release, suggesting activation of extrinsic pathways followed by
mitochondria-mediated cytochrome c release through the intrinsic pathway, type II cell
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extrinsic apoptosis pathway and/or feed-forward amplification from the initial extrinsic
signal (115). However, specific contributions from extrinsic or intrinsic mechanisms have
not been determined.
Available data indicate pervasive effects of nsPEF on all cell membranes inducing
apoptosis signaling in several cell types. However, their mechanisms, sites of action and
unambiguous confirmation of apoptosis pathways contributing to cell death have not
been clearly determined. In this study, we demonstrate direct activation of apoptosis
signaling through multiple mechanisms and quantify relative contributions from several
apoptosis pathways originating from both plasma membranes and intracellular
membranes that exhibit both dependence and independence of caspases, calpains,
calcium, and cytochrome c release. Several quantified nsPEF-induced biological
functions exhibit different electric field sensitivities and kinetics that promote
heterogeneous apoptosis characteristics in E4 squamous carcinoma cells (SCC). Diverse
effects of nsPEFs on different E4 SCC death mechanisms and programmed pathways can
induce cell death by multiple mechanisms bypassing apoptosis-deficient syndromes in
SCC.
MATERIALS AND METHODS
Cells and cell culture—The E4 murine squamous cells were obtained from Dr.
Jian-Hua Mao (Lawrence Berkeley National Laboratories) and were maintained in
Dulbecco's modified Eagle's medium (ATCC) supplemented with 10% fetal bovine
serum (FBS, Atlanta Biologicals), 2mM L-glutamine (Mediatech Cellgro), and 1%
Penicillin-Streptomycin solution (Mediatech Cellgro). The cells were cultured in a humid
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atmosphere containing 5% CO2 and 95% air at 37°C until reaching 50-75% confluency
with passage ranging between 11 and 19.
Induction of cell death by nanosecond pulsed electric fields—Cells were
harvested with trypsin and resuspended in fresh DMEM medium with 10% FBS to a
concentration of 7.7x 10 cells/ml. 130ul of cell suspension (1x10 cells) were placed in
0.1 cm gap cuvettes (Biosmith) and exposed to ten pulses with 300ns duration and
electric field strength from 0-60 kV/cm. The pulse power devise was previously
described (115). The energy absorbed or the dose (J/g) was calculated as previously
described (142). The Frank Reidy Research Center for Bioelectrics provides a course to
present the safe use of high voltage pulse power equipment. The authors have been
trained in the safe use of this equipment. For all cell responses, time courses were
conducted to determine time for maximal responses. Cell responses at all electric fields
were stable for at least 90 minutes.
Determination of24hr cell survival—After treatment, E4 cells were seeded in 6well plates (3.3xl0 5 cells/well). Twenty four hours later, cells were detached and trypan
blue negative cells were counted. The cell numbers were normalized to control cells as
100%.
Assessment ofcaspases-3 & -7, -8, -9 activation by flow cytometry—Caspase-3&7,-8, -9 activation were assayed using a commercial method based on fluorochromelabeled, irreversible caspase inhibitors (FLICA, Immunochemistry Technologies LLC).
E4 cells were treated with different nsPEF conditions as mentioned above. One hour after
treatment, cells were gently removed from cuvettes and resuspended in DMEM without
FBS. According to the manufacturer's recommendations, cells were labeled with
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carboxyfluorescien caspase-3 &-7, -8, -9 irreversible inhibitors for 1 hour at 37°C under
5% CO2 and protected from light as previously described (105). Cells were washed with
buffer to remove the unbound reagent. Cell fluorescence was determined by Becton
Dickinson FacsAria. Ten thousand (10,000) cells were acquired for analyses and
expressed as percentage of cells showing positive fluorescence. As electric fields were
increased, greater numbers of cells became caspase positive with homogeneous shifts of
cells into the caspase positive gate, making cell percentages with active caspases the most
accurate and meaningful quantification of active caspases as an apoptosis marker.
Evaluation ofactive pan-caspase by flow cytometry—E4 cells were exposed to
specific nsPEF conditions as previous described and incubated with 40uM fluorescentlabeled, cell permeable, irreversible inhibitor FITC-VAD-fmk (CaspACE™, Promega)
for 20 min. Cells were washed once with 1ml PBS and resuspended in 500uL PBS 1 hour
post pulse for flow cytometric analysis with Becton Dickinson FacsAria.
Measurement of cytochrome c release by two different assays—Cytochrome c
release was measured by two different methods, which gave similar results (data not
shown). In method I cytochrome c, which was used in all studies here, was assessed using
the Innocyte Flow Cytometric Cytochrome c Release assay (Calbiochem). One hour after
nsPEF treatment, cells were permeabilized, fixed and washed. Cells were then incubated
with primary antibody overnight at 4°C and secondary antibody for 1 hour at room
temperature. Cells (10,000) were then analyzed by Becton Dickinson FacsAria flow
cytometer. Method II data is not shown but was carried out as previously described (105,
115).
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Measurement of mitochondrial membrane potential (Ay/m)—Depolarization of
the mitochondrial membrane potential was detected using a fluorescent lipophilic cation,
tetramethylrhodamine ethyl ester (TMRE) (Immunochemistry Technologies LLC). Cells
were incubated with 200nM TMRE for 10-20 min at 37°C 30 min post pulse. Twenty
(20) minute incubations were suggested by the manufacturer, but 10 min incubations,
which gave similar results, were used in some experiments to determine the earliest
response. At the end of incubation, cells were resuspended in assay buffer. The average
intensity of red fluorescence (10,000 cells) was analyzed on the FL-2 channel of a Becton
Dickinson FacsAria flow cytometer.
Determination of phosphatidylserine externalization—External PS exposure and
plasma membrane permeability was evaluated by double-labeling cells with FITCAnnexin-V and PI using a detection kit (BD Pharmingen Biosciences). After
administration of nsPEFs, cells were resuspended in binding buffer and incubated with
FITC-Annexin-V and PI according to the manufacture's procedures. The fluorescence
signal was quantified by flow cytometry using FL1 (Annexin-V) and FL2 (PI) channels
15 minutes post pulse.
Assessment of cytochrome c release with administration of z-VAD-fmk—Cells
were preloaded with lOOuM of z-VAD-fmk for 30 min and followed by exposing cells to
ten 300ns pulses with 0 and 60 kV/cm electric fields. Cytochrome c monoclonal antibody
(BD Pharmingen Biosciences) and Alexa-Fluor 488 goat anti-mouse antibody
(Invitrogen) were added to cell suspensions lh after pulsing as described previously
(105). Flow cytometric analysis of fluorescent intensity was done by using Becton
Dickinson FacsAria.
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Immunoblot analysis for Bcl-2, Bcl-xl, Bid and t-Bid—For each antigen samples
were taken for immunoblot analysis 0, 15, 30 and 60 min after pulsing. Bcl-2 and Bcl-xl
data are not shown. At the indicated times E4 cells were washed twice with cold PBS and
lysed in RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 0.1% SDS) (Pierce) for 30 min on ice. Then cell lysates were centrifuged
at 15,000g for 20 min at 4°C and protein content in the supernatant was measured using
the BCA method (Pierce). Lysates were then boiled with 4x DualColor™ Protein
Loading Buffer (Fermentas Life Sciences) for 5 min. Protein extracts (75 ug) were
separated by electrophoresis on 15% SDS-polyacrylamide gel electrophoresis (SDSPAGE) and proteins were transferred onto a PVDF membrane with pore size of 0.2um
(Pierce, Rockford, IL). Membranes were blocked in Odyssey blocking buffer (LI-COR
Biosciences) for 1 hour, and incubated overnight at 4°C with the respective primary
antibody directed against Bcl-2 (1:200 mouse polyclonal, Santa Cruz Biotechnology),
Bcl-xl (1:1000 rabbit monoclonal, Cell Signaling Technology), or Bid/t-Bid (1:100
mouse monoclonal, R&D System) diluted in blocking buffer. Membranes were washed
three times with 0.1% Tween-20 in PBS and then incubated with an IRDye680conjugated secondary antibody (LI-COR Biosciences) in blocking buffer for lhr.
Protein-antibody complexes conjugated with IRDye 680 were quantified on the Odyssey
Infrared Imaging System (LI-COR Biosciences). |3-Actin (1:1000; Li-Cor Biosciences)
was used as loading control.
Assessment of inhibitory effects of z-VAD-fmk, EGTA and BAPTA on nsPEFs
induced-Bid cleavage—E4 cells were preincubated with lOOuM z-VAD-fmk, 5mM
EGTA, and/or 20uM BAPTA-AM, for 30 minutes followed by nsPEFs treatment. Cells
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were then quantified by immunoblot analysis using Odyssey for levels of Bid and t-Bid
as described above. Caspase-dependence was determined by Bid cleavage that was
inhibited by z-VAD-fmk. Calcium dependence was determined by Bid cleavage that was
inhibited by EGTA and BAPTA-AM in the absence of z-VAD-fmk. Dependence on
extracellular calcium was determined by Bid cleavage that was inhibited by EGTA in the
presence of z-VAD-fmk. Dependence on total calcium was determined by Bid cleavage
in the presence of EGTA and BAPTA-AM in the presence of z-VAD-fmk. Dependence
on intracellular calcium was determined by the difference between total calcium and
extracellular calcium responses.
Assessment of calpain activity in response to nsPEFs by fluorometric
assay—Analysis of calpain catalytic activity was determined in total cell lysates
(BioVision). Cell lysates were prepared and incubated with substrate (AC-LLY-AFC)
and reaction buffer for 1 hour at 37°C in the dark. Cleavage substrate fluorescence was
measured by a microplate spectrofluorometer (ex/em = 488/520 nm) with SoftMax Pro 5
software (Molecular Devices). A calpain-specific inhibitor (z-LLY-fmk) was used to
identify calpain-specific substrate hydrolysis. Recombinant calpain I was used as positive
control (data not shown).
Determination of intracellular Reactive Oxygen Species (ROS)
accumulations—E4 Cells were preloaded with 1 uM CM-H2DCFDA (5-6-chloromethy2', 7'-dichlorodihydrofluorescein diacetate acetyl ester, Molecular Probes) in phenol red
free DMEM media (Invitrogen) for 60 minutes, and then pulsed with nsPEF as described
previously (105). Cells were analyzed by flow cytometry at 0, 5, 15, 30, and 60 min after
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pulsing. Cells incubated at 4°C for lhour were used as positive controls. After removing
from the cold, these cells were also sampled at 0, 5, 15, 30 and 60 min.
Statistical analysis—Experiments were performed at least three times
independently in this study. All the data is expressed as mean ± standard error (SE).
Statistical differences between control and treated groups were analyzed by student's ttest (two-tailed) with/) < 0.05 regarded as statistically significant.
RESULTS
NsPEFs induce caspase-correlated cell death in E4 squamous carcinoma cells
(SCC) in vitro in an electric field-dependent manner—To determine cell viability after
nsPEF treatment and whether nsPEFs activate caspase-associated cell death pathways in
E4 SCC, cells were exposed to ten 300ns pulses of 0-60 kV/cm electric field strengths.
We chose ten, 300ns pulses as parameters for this study so we could observe a complete
range of electric field-dependent effects on cell survival from little of no cell death to
maximal cell death. Thus, we could observe various cell responses as possible
mechanisms that were coincident with cell death. Cell viability was determined by
counting trypan blue negative cells 24 hours post pulse (Fig. 1, top panel). Caspase-3/7, 8, -9 activations were determined 2 hours after nsPEF administration by flow cytometry
using a cell permeable, irreversible inhibitors with selectivity towards specific caspase
isoforms (Fig. 1, bottom panel). Results indicate an electric field-dependent decrease in
cell viability that was correlated with electric field-dependent increases in percentages of
cells that exhibited active caspases. Analysis of caspase activation time courses indicated
that they were activated between 20 and 60 minutes post-pulse using the cell permeable,
pan caspase irreversible inhibitor, z-VAD-fmk (data not shown). Therefore, nsPEF-
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induced E4 cell death is correlated with early caspase activation. Very few if any cells
immediately lose plasma membrane integrity indicating that frank necrosis is not a
mechanism of cell death.
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FIGURE 1. NsPEF-induced cell death is correlated with the
activation of caspase-3/7, -8, and -9 in an electric field amplitudedependent manner. E4 cells were pulsed 10 times at 300ns and
electric field strengths between 0-60 kV/cm. (Top panel) Cell
viability was determined by counting trypan blue negative cells 24
hours post pulse and normalizing values to the control. (Bottom
panel) The percentage of cells with active caspase-3/7, -8, -9 was
analyzed by flow cytometry using the cell permeable irreversible
caspase inhibitors FAM-DEVD-fmk (caspase-3), FAM-LETD-fmk
(caspase-8), FAM-LEHD-fmk (caspase-9) as described in Materials
and Methods. The values represent the mean± SE (n=3) * indicates/?
< 0 05 and ** indicates/? < 0.01.

Different sensitivities and heterogeneous responses in E4 cells to nsPEFs:
Electric field-dependent effects on plasma membrane indicators, Ay/m, caspase activation
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and cytochrome c release—Fig. 2 shows electric field thresholds for five different cell
functional indicators in response to nsPEFs as defined by significant increases in cell
numbers above basal values in the absence of electric field exposure. These cell
responses also exhibited different temporal thresholds that were determined by time
courses (data not shown) prior to experiments shown in Fig. 2. These values are indicated
with each response. Significant numbers of cells showed increases in PI uptake and
phosphatidylserine externalization at 24 kV/cm, indicating changes in permeability and
phospholipid orientation in plasma membranes. These plasma membrane responses were
present as quickly as they could be measured (minutes) and were stable thereafter for at
least 2 hours. Fig. 2 illustrates these analyses 15 minutes after pulsing. These effects on
plasma membranes were electric field-dependent. Essentially all of the cells (95-98%)
were positive for both markers at electric fields > 42 kV/cm. Cell responses below 42
kV/cm were heterogeneous for both of these markers with only about 35% and 70% of
cells showing positive responses at 24 and 32 kV/cm, respectively. For effects on the
mitochondria membrane potential, a significant increase in the numbers of cells that
exhibited decreases in A\\im were observed at 42 kV/cm, indicating depolarization of the
inner mitochondria membrane. Increases in the numbers of cells that showed decreases in
A\|/m were seen within 10 minutes, the earliest time measured. Fig. 2 shows the response
with TMRE 15 minutes post pulse. Similar results were observed with JC-1 (data not
shown). Significant increases in the number of cells expressing active caspases occurred
at 32 kV/cm and increased in an electric field dependent manner. Cell numbers with
active caspases are shown in Fig. 2 one hour after pulsing. The temporal threshold for
increases in cells positive for active caspases was between 20 and 60 minutes.
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Cytochrome c release required higher electric fields with significant increases in the
numbers of cells releasing cytochrome c occurring at 42 kV/cm. Thus, cytochrome c was
the least sensitive indicator tested, was not readily discernable before 1 hour and only
showed positive responses in about 45% of cells. The 1 hour time point is shown in Fig.
2. We used two different assays for cytochrome c releases (see Materials and Methods),
both showing thresholds at 42 kV/cm and no significant differences between them at any
electric field tested (data not shown). Notice that cell membrane responses (PI, AnnexinV and A\|/m) were evident at the earliest time tested while biological responses (caspase
activation, cytochrome c release) required more time. Also notice that at electric fields
lower than 42 kV/cm, cell numbers with increases in active caspase and decreases in
A\|/m were observed without significant cytochrome c release. At electric fields greater
than 50 kV/cm, greater numbers of cells exhibited caspase activation than those with
decreased A\|/m and released cytochrome c. At electric fields 50 kV/cm and higher, equal
numbers of cells exhibited decreases in A\|/m and increases in cytochrome c release and
30-40% of cells did not show active caspases and about 55% did not show decreases in
A\|/m or increases in cytochrome c release. Although the temporal thresholds were
different for some of these responses, they were stable for at least 90 minutes under the
conditions tested. Thus Fig. 2 can represent a 1 hour snapshoot after treatment. However,
cell responses indicate that these membrane and intracellular markers exhibit
heterogeneous responses, different electric field sensitivities and different time courses.
Caspase-dependent and caspase-independent cytochrome c release in response to
nsPEFs—To determine whether cytochrome c is released through the intrinsic pathway
or type II cell extrinsic pathway, E4 cells were pretreated with 100 uM z-VAD-fmk, a
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general caspase inhibitor, and then pulsed ten times at 300 ns, 60 kV/cm in the presence
of the inhibitor (Fig. 3). Inclusion of 1 mM z-VAD-fmk gave identical results (data not
shown); indicating that caspase activity was completely inhibited at 100 uM. Cytochrome
c release was determined 1 hour post pulse by flow cytometry using Method I (see
Materials and Methods). Fig. 3A shows a contour plot of a typical experiment
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FIGURE 2. Sensitivity thresholds for nsPEF effects on cell membranes, caspase activation and
cytochrome c release. E4 cells were exposed to 10 pulses at 300 ns ranging from 0-60 kV/cm and
percentage of cells that showed significant responses were analyzed by flow cytometry for decreases in
the mitochondrial membrane potential (A\|/m) with TMRE 15 minutes post pulse, active caspases with
FITC-VAD-fmk 1 hour post pulse, and cytochrome c using the InnoCyte (Method I) one hour post
pulse. FITC-Annexin-V and propidium iodide were added immediately after nsPEF exposure and
incubated for 15 minutes before analysis by flow cytometry. After initial measurements all responses
were stable for a given electric field for at least 90 minutes. Values are presented as percent cells with
positive responses. The graph represents the mean ± SE (n=3). * indicates/? < 0.05 and ** indicates/? <
0.01.

with forward scatter on the Y-axis (FSC-A) and cytochrome c fluorescence on the X-axis
(FITC-A). Cells that exhibit cytochrome c release appear in the bottom right quadrant.
Fig. 3B shows the combined results of three separate experiments with statistical
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comparisons. In sham treated control cells, very few cells show cytochrome c release (7.7
± 1.5%) and the caspase inhibitor has no significant effect (9.5 ± 2.2%). When cells were
treated with ten 300ns pulses at 60 kV/cm, 46.2 ± 2.5% of cells exhibited cytochrome c
release and the caspase inhibitor decreased that to 26.2 ± 4.6%. Three separate
determinations gave similar results (Fig. 3B). Thus, based on the mean values in these
experiments 43.3% of cytochrome c release was caspase-dependent and 56.7% was
caspase-independent, indicating more than one mechanism for cytochrome c release in
response to nsPEFs.

control

A.

control+Z-VAD-fmk

FIGURE 3. A caspase inhibitor (z-VAD-fmk) partially decreases nsPEF-induced
cytochrome c release. E4 cells were pre-incubated with lOOuM z-VAD-fmk, a pan caspase
inhibitor, for 30min and then pulsed ten times with 300ns pulses at 60 kV/cm or sham
treated. Cells were analyzed by flow cytometry for cytochrome c release 1 hour post pulse
using Method I as described in Materials and Methods. A, Representative contour plots are
shown with forward light scatter (FSC-A) on the Y axis and cytochrome c fluorescence
(FITC-A) on the X-axis. The top panels show sham treated control cells in the absence (left)
and presence (right) of z-VAD-fmk. The bottom panels show cells treated with nsPEFs in
the absence (left) and presence (right) of z-VAD-fmk. A decrease in cytochrome c release is
shown as a decrease in fluorescent intensity (shift from lower right quadrant to lower left
quadrant) after preincubation with lOOuM z-VAD-fmk. B, The percentage of cells
exhibiting cytochrome c release is presented as mean ± SE (n=3). ** represents/) < 0.01.
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NsPEFs generate Bid cleavage to truncated Bid (t-Bid)—A well-characterized
mechanism for caspase-dependent cytochrome c release is through the cleavage of the
BH3 only protein, Bid to the pro-apoptotic form t-Bid (40). Such a possibility was also
likely given that caspase activation was observed at lower electric fields and earlier times
than cytochrome c release. To determine if t-Bid was present, we analyzed cells that were
exposed to ten 300ns pulses at 60 kV/cm and then used immunoblot analysis to determine
the quantities of Bid and t-Bid using quantitative Odyssey imaging at times after
treatment with an antibody that recognized both Bid forms (Fig. 4). The left panel shows
a typical immunoblot experiment of Bid and t-Bid in response to ten 300ns pulses at 60
kV/cm, a condition that resulted in significant cytochrome c release (see Fig. 2 and 3).
The panels on the right show quantitative relationships of relative percentages oft-Bid
(top) and Bid (bottom) over a 60 minute time course. In a time-dependent manner, there
were increases in t-Bid and coordinate decreases in Bid. The sums of fluorescence
intensities of both Bid forms were essentially the same at each time point, consistent with
nsPEF-induced cleavage of Bid to generate pro-apoptotic t-Bid. At 60 minutes after
treatment, nearly all Bid had been cleaved and pro-apoptotic t-Bid.
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FIGURE 4. NsPEFs induce Bid cleavage in a time-dependent manner in E4 cells. E4 cells were
exposed with or without ten 300ns pulses at 60 kV/cm. Whole cell extracts (75 ug protein) were
separated by SDS-PAGE, transferred to PVDF membranes and probed with an anti-Bid antibody.
(Left panel) Bid (22 kDa) and t-Bid (15 kDa) levels were determined 0, 15, 30 and 60 minutes post
pulse by immunoblot analysis in a representative experiment as described in Material and Methods.
Quantification was performed after normalizing Bid (0 min) or t-Bid (60 min) to maximal levels. The
right panel shows quantification of three experiments like the typical one shown in the left panel.
Values > 30 minutes are statistically significant (** is/? < 0.01).

NsPEFs induce caspase-dependent and calcium-dependent Bid cleavage;
Repetitive mechanisms for cytochrome c release—The data in Fig. 3 using z-VAD-fmk
indicated that nsPEF-induced cytochrome c release, which is regulated at least in part by
Bid cleavage, could be accounted for through caspase-dependent and caspaseindependent mechanisms. Since nsPEFs induced Bid cleavage and proteases other than
caspases can cleave Bid, including calcium-dependent calpains (44, 92), we investigated
the caspase- and calcium-dependency of Bid cleavage in response to nsPEFs (Fig. 5) as
well as the possibility for nsPEF-induced calpain activity (Fig. 6). It was also of interest
to determine whether the calcium was mobilized from intracellular stores, suggesting an
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intrinsic mechanism, or from extracellular media through plasma membranes as an
extrinsic mechanism. Caspase-dependence was determined in the presence and absence
of z-VAD-fmk and the absence of EGTA and BAPTA. Determining caspase-dependent
Bid cleavage in the presence of calcium was justified by the observations that caspase
activity was shown to be independent of calcium (105, 115). Calcium dependence was
determined in the presence and/or absence of EGTA and BAPTA-AM. These analyses
considered Bid cleavage to be either caspase- or calcium-dependent. To determine total
calcium dependence from intracellular and extracellular compartments, caspases were
inhibited by z-VAD-fmk. Thus, these values represent only the calcium component. The
effect of extracellular calcium was determined in the presence and absence of EGTA and
total calcium effects were determined in the presence and absence of EGTA and BAPTA.
Intracellular calcium dependence was determined by the differences in total and
extracellular calcium effects. The analyses were carried out in five to seven separate
experiments by quantitative immunoblot analysis using Odyssey imaging of Bid
experiments shown in Fig. 4. The results in Fig. 5 show that about 60% of Bid cleavage
was attributed to caspases, while about 50% was attributed to calcium-dependent
proteolysis. The differences are not statistically different, suggesting that effects of
caspase- and calcium-dependent mechanisms contribute about equally to Bid cleavage.
These slightly overlapping percentages could be due to a small amount of crossdependence for caspase and calcium requirements, but are within reason of experimental
variations. Further analyses indicated that 60-70% of the calcium contributing to Bid
cleavage comes from extracellular sources through plasma membranes and 30-40%
comes from intracellular stores.
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NsPEFs induce calpain activity—It was possibility that calcium-dependent Bid
cleavage in response to nsPEFs was due to calpain activation. To test this, E4 cells were
treated with ten 300ns pulses at 60 kV/cm in the presence or absences of BAPTA and
EGTA, which inhibits intracellular and extracellular calcium-mediated events,
respectively, and z-LLY-fmk, which specifically inhibits calpain activity. One hour after
treatment cell extracts were prepared and assayed for calpain activity using the substrate
AC-LLY-AFC. In the absence of these inhibitors/chelators, basal calpain activity was
about 50 units and nsPEFs increased this activity 1.7-fold. In the presence of the calpain
inhibitor, both basal and nsPEF-stimulated activities were decreased by about 50%. In the
presence of BAPTA and EGTA, basal activity was not significantly affected, but nsPEFstimulated activity was inhibited by >50%. When calcium chelators and the calpain
inhibitor were present, basal activity was not inhibited any greater than when the calpain
inhibitor was present alone. NsPEF-stimulated activity was inhibited by >80%. This data
indicate that E4 cells exhibit calcium-insensitive basal calpain activity and calciumsensitive nsPEF-stimulated activity. Although not tested here, these data suggest that
other protease activities might be activated by nsPEFs.
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FIGURE 5. Inhibition of Bid cleavage by calcium chelators EGTA and BAPTA and
caspase inhibitor z-VAD-fmk. E4 cells were pre-incubated for 30min in the presence or
- absence of EGTA (5mM, to chelate extracellular calcium), BAPTA-AM (20uM, to chelate
intracellular calcium) and/or z-VAD-fmk (lOOuM to inhibit caspase activation) prior to
nsPEFs administration. Cells were exposed to ten 300ns pulses at 60 kV/cm or sham treated
and cell lysates were prepared 1 hour post pulse as described in Material and Methods. Bid
and t-Bid was quantified using Odyssey infrared imager (see Figure 4) and normalized to total
Bid levels in control. Caspase-dependent Bid cleavage was taken as the percent cleavage
inhibited by z-VAD-fmk. Calcium-dependent Bid cleavage was taken as cleavage inhibited by
BAPTA and EGTA. To determine only calcium contributions, z-VAD-fmk was used to
inhibit the caspase component. Total calcium-dependent (intracellular plus extracellular) Bid
cleave was taken as cleavage that wasinhibited by EGTA and BAPTA. Extracellular calciumdependent Bid cleavage was taken as cleavage inhibited by EGTA. Intracellular calcium
dependent Bid cleave was taken as the difference between cleavage of the total calcium
component minus the extracellular calcium component. Values are expressed as mean ± SE
(n=5-7). * indicatesp< 0.05
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FIGURE 6 NsPEFs induce calcium-dependent calpain activity in E4
cells. Calpain activity was determined by a calpain activity assay. E4 cells
were pretreated with or without BAPTA-AM (20 uM) and EGTA (5mM) for
30 min followed by exposing to ten 300ns at 60 kV/cm or left untreated. Cells
were then lysed and calpain activity was determined with or without adding
calpain inhibitor z-LLY-fmk (200 uM) to lysates. Data are expressed as mean
± SE (n=3). * indicates/? < 0 05.

NsPEFs induce cell death without ROS generation or changes in pro-survival
protein Bcl-2 and Bcl-xl—To determine whether ROS generation contributes to nsPEFinduced apoptosis, E4 cells were pulsed in the presence of CM-H2DCFDA and mean
fluorescence intensity was analyzed by flow cytometry 0, 5, 15, 30, 60 min post pulse
(Fig. 7). Treatment of cells for 1 hour at 4°C increased ROS by 5-fold. ROS levels
quickly decreased in a time-dependent manner to near control levels by 1 hour,
demonstrating significant antioxidant activity in E4 SCC. In response to nsPEFs E4 cells
show a slight electric field dependent increases that were not statistically significant.
Unlike the positive control, no time dependent decreases in ROS levels were observed
after pulsing. These results suggest that nsPEFs have minimal effects ROS generation
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and that E4 cells exhibit active antioxidant activities, which is often typical for cancer
cells.
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FIGURE 7. Measurements of ROS generation in E4 cells after nsPEFs
exposure. E4 cells were preincubated with ROS indicator CM-H2DCFDA for 60
minutes and exposed to ten pulses at 300ns between 0-60 kV/cm. Intracellular ROS
formation was evaluated by measuring fluorescent intensity 5, 15, 30, 60 min post
pulse by flow cytometer. For the positive controls cells incubated at 4°C for lh and
removed at the indicated time for measurement of ROS levels. The graph represents
the mean ± SE (n=3). ** represents p< 0.01 for differences at the indicated time
compare to the control at 0 kV/cm.

NsPEF have no significant effects of Bcl-2 or Bcl-xl levels—In a further analysis
of nsPEF effects, levels of the anti-apoptotic proteins Bcl-2 and Bcl-xl were analyzed in
the absence and presence of nsPEF treatment in E4 cells using quantitative immunoblot
analysis with Odyssey imaging (data not shown). Both Bcl-2 and Bcl-xl were present a
single bands in control cells. There were no effects often 300ns pulses at 60 kV/cm on
either anti-apoptotic protein with the first hour after treatment with nsPEFs, suggesting
that anti-apoptotic protein levels were unaffected while a pro-apoptotic protein, Bid was
activated.
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DISSCUSSION
Evidence from E4 SCC gives new insight and understanding for cell death and
apoptosis-like mechanisms and their origin in response to nsPEFs. In the experiments
presented here we quantified a diverse set of cell responses to nsPEFs in E4 SCC. The
results indicate that cell death can be dependent and/or independent of caspase activity,
calpain activity, calcium from intracellular stores or extracellular media, cytochrome c
release and decreases in A\j/m. Thus, nsPEFs initiated charge-mediated events in plasma
membranes and intracellular membranes through multiple signaling mechanisms
inducing signatures of apoptosis and other forms of cell death. Even at the highest
electric fields investigated, frank necrosis as defined by immediate plasma membrane
rupture was not present, so cell death is driven by biological responses that appear to be,
at least in part, programmed. Ibey et al. (143) found that apoptosis (DNA fragmentation
of agarose gels) was present in U937 cells exposed to 600 pulses at 10 ns and 100 kV/ cm
(700 J/g); however, necrosis was a major form of cell death. However, in this study the
cell type was different and the energy absorbed or dose (J/g) for the pulses was about
seven times higher than in the present study (-700 vs. -100 J/g). It should be pointed out
that factors other than energy absorbed are likely involved to determine nsPEF effect
(144).
After treatment with nsPEFs caspases are activated at earlier times and at lower
electric fields than cytochrome c release, demonstrating initial activation of a type I cell
extrinsic pathway. This is similar to results in nsPEF treated HCT-116 colon carcinoma
cells (115), but different than B16fl0 cells that did not release cytochrome c (105) and
Jurkat cells with concomitant cytochrome c release and caspase activation (101). This
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clearly defines cell type-specific response to nsPEF-induced cell death. Unlike the other
analyzes, here we show for the first time caspase-dependent and caspase-independent
cytochrome c release, demonstrating the additional presence of a type II cell extrinsic
pathway through Bid cleavage for cytochrome c release. Caspase-dependent (55-60%)
and calcium-dependent (40-45%) Bid cleavage pathways were demonstrated with
quantitative and reciprocal increases in t-Bid and decreases in Bid. Further, for calciumdependent Bid cleavage, extracellular calcium (-70%) played a predominant role
compared to calcium from intracellular stores (-30%). Caspase-independent Bid cleavage
is most likely accomplished by charge-mediated interventions with calcium signaling
from and/or nanoporation in the endoplasmic reticulum, capacitative calcium entry (107,
109) and/or calcium entry through nanopores in plasma membranes (140). Since caspase
activation has been shown to be calcium-independent (105, 115), calcium-dependent Bid
cleavage appears to be due to calpain activation. This was confirmed by showing
calcium-sensitive calpain activity was specifically inhibited by the calpain inhibitor zLLY-fmk. Taken together, these results show for the first time nsPEF-mediated at least
two mechanisms for Bid cleavage and cytochrome c release—one caspase-dependent and
one calpain-dependent. While there are reports of cross-talk and/or synergistic behaviors
between calpains and caspases (95, 145), since the sum of caspase-dependent and
calpain-dependent Bid cleavage activities, which were determined independently of the
other, equal about 100% of total Bid cleavage. Generation oft-Bid, a critical point
connecting extrinsic and intrinsic pathways, by at least two different protease families
provides beneficial repetitive mechanisms to maximize cytochrome c release and
apoptosis induction through mitochondria pathways. Thus, nsPEFs promote pro-apoptotic
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signals that overcome resistances to apoptosis, which are present in most if not all
cancers, thereby potentially abolishing the universal cancer hallmark of apoptosis evasion
(122).
By analyzing several different E4 cell responses to nsPEFs by flow cytometry, it
was possible to establish several other characteristics for nsPEF-induced cell death.
Under nsPEF conditions that eliminated >95% of E4 SCC, only 50% of cells exhibited
cytochrome c release and decreases in A\|/m, while 75-80% of cells exhibited active
caspases. Moreover, each of these responses showed different thresholds or sensitivities
among themselves, with cytochrome c release as the least sensitive response. Sensitivities
for plasma and inner mitochondria membrane permeability appeared to be similar,
although plasma membrane reactions as determined by PI uptake and PS externalization
were overall more responsive than inner mitochondria membrane as determined by
decreases in A\|/m. These are most likely due to nanopore formation in the respective
membranes. These results are consistent with an overall greater initial response from
plasma membrane sensitivity leading to activation of extrinsic apoptosis mechanisms
compared to intrinsic mechanisms from mitochondria membrane sensitivity. An extrinsic
mechanism is also consistent with a greater response from extracellular calcium and a
lesser response from intracellular calcium.
The predominance of extrinsic mechanisms with greater effects on plasma
membranes and from extracellular calcium-dependent responses compared to intrinsic
mechanisms measured by decreases in A\|/m and intracellular calcium-dependent
responses can possibly be explained by characteristics of electric fields pulses. Pulsed
electric field requirements for intracellular membrane effects include a fast pulse rise
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time, high electric fields, and a pulse duration that is shorter than the relaxation time of
intracellular membrane, which is on the order of- 100 ns (104). While pulses used here
have sufficient rise times and electric fields (<4 ns and 60 kV/cm, respectively), the
relatively long 300 ns pulse duration may not be short enough to allow fully effective
intracellular effects. While the mechanism(s) for caspase activation remains to be
defined, nsPEF effects are due to membrane charging events. While PI uptake occurs in
>95% of cells, and cytochrome c is released in about 50% of cells, caspases are activated
in 75-80% of cells. This suggests that charging of the plasma membrane may be more
closely tied to caspase activation than charging of intracellular membranes. This is
consistent with caspase activation occurring before cytochrome c release, reminiscent of
the type I cell extrinsic mechanism, and greater numbers of cells exhibiting PI uptake at
lower electric fields than cells with decreased Av|/m. At the highest electric field tested
(60 kV/cm), all of these nsPEF induced responses are coincident with cell death in >95%
of cells indicating heterogeneous cell responses in nsPEF-induced cell death. Given that
- 75-80% of cells express active caspases, caspase-associated cell death appears to be a
predominant event. Thus, cell death occurs against different backgrounds of mitochondria
responses in A\|/m, cytochrome c release and caspase activation. While decreases in A\|/m,
caspase activation and cytochrome c release may all occur within given populations of
cells, other cell populations may exhibit one or more of these, most notably through the
cytochrome c-independent extrinsic pathway(s). Thus, nsPEF-induced apoptosis
mechanisms are heterogeneous within E4 SCC populations as well as heterogeneous
among cell types (101, 115).

50
Special consideration should be made for using PI uptake as a cell viability
marker and phosphatidylserine externalization as an apoptosis marker in response to
electric field stimulation. Using PI as a viability marker could be misleading given that
electric fields have transient and reversible effects on membrane permeability. Some cells
can survive after conventional electroporation as well as after sub-lethal nsPEF
conditions (146). Thus, to avoid possible erroneous conclusions when evaluating effects
of electric field on plasma membranes it is not advisable to use PI uptake as a viability
marker. In the studies here, 300 ns pulse durations are long enough to allow plasma
membrane pores to expand so they are large enough to include PI, which is on the order
of about a nanometer. Nevertheless, the pulse durations are short and fast enough to
induce intracellular membrane effects. Moreover, modeling evidence indicates that
nsPEFs can ' 'pull" phosphatidylserine through nanopores (117, 147-150) acting as an
apoptotic mimic that in the presence of macrophages was shown to cause phagocytosis of
caspase-negative cells (151). Thus, to avoid possible erroneous conclusions,
phosphatidylserine externalization should not be used as an apoptosis marker or used
very cautiously when evaluating effects of electric fields on plasma membranes.
Particularly, PI and Annexin-V should not be used alone as indicators for
viability/necrosis and apoptosis, respectively, when evaluating effects of electric fields or
other stimuli. In addition, defining apoptosis characteristic in vitro can be complicated by
the presence of artifacts that are not present during apoptosis in vivo. In this study, events
within the first 2 h were a primary focus to avoid or lessen these issues. While time
courses for cell death are stimuli-dependent, nsPEF effects occur relatively rapidly in E4
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cells. What can be discerned in this time fame, especially within the first hour(s), is
reported in this study.
There may be a case made for a unique type of nsPEF-induced cell death. Cell
death initiated by nsPEFs can be differentiated from TNF-induced necroptosis, H2O2induced necrosis and anti-Fas-induced secondary necrosis (152) in that nsPEF, in contrast
to cold exposure, did not exhibit ROS generation determined with CM-H2DCFDA and
did not lead to hyperpolarization of A\j/m as the other stimuli-induced cell death did.
Thus, E4 SCC mechanisms that protect against DNA and other damage from ROS are not
expected to be effective in response to nsPEFs. Given that electric fields with nsPEF
characteristics do not exist in nature, nsPEFs provide a distinct cell death stimulus, which
could account for the heterogeneity of nsPEF-induced responses in E4 SCC.
In E4 cells, new evidence is provided that nsPEFs act through multiple
mechanisms to induce cell death at least in part due to apoptosis through extrinsic type I,
extrinsic type II and/or intrinsic pathway(s). Based on several lines of evidence, the type I
extrinsic pathway appears to be predominant among these. While calpain activation can
be initiated by mobilization of calcium from intracellular and/or extracellular sources by
nanopore formation, it remains to be determined how a presumed plasma membrane
stimulus leads to caspase activation. The extrinsic pathway is activated by plasma
membrane death receptors. It is possible that electric field interactions with the plasma
membrane could activate these receptors either through nanopore formation or some
other charging event that rearranges lipid bilayers. Alternatively, changes in membrane
permeability could alter the intracellular milieu, such as apoptosis volume decrease (153),
leading to caspase activation. Aside from caspase activation other mechanisms are likely
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to contribute to nsPEF-induced cell death. Since necrosis induced by immediate plasma
membrane rupture is not a significant cause of E4 SCC cell death, nsPEFs must set into
motion events that are mediated by biological mechanisms in response to nsPEFmediated stresses that are at least in part programmed.
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CHAPTER III
NANOSECOND PULSED ELECTRIC FIELDS (NSPEFS) INDUCE APOPTOSIS
VIA MITOCHONDRIAL INTRINSIC PATHWAY IN JURKAT CELLS

ABSTRACT
To determine whether nanosecond pulsed electric fields (nsPEFs) induced
apoptosis through the extrinsic and/or intrinsic pathway we used human wild-type (WT)
Jurkat cells and Jurkat clones that were deficient in either FADD (AFADD) or caspase-8
(Acas-8). To determine molecular mechanisms of apoptosis, we show in all clones treated
with nsPEFs evidences of apoptosis, including irreversible decreases in mitochondrial
membrane potential (A\|/m), cytochrome c release, activation of caspases, H2AX
phosphorylation and Bid cleavage. In contrast to Fas-mediated cell death (CH-11
antibody), which only exhibited cell death in WT, nsPEFs induced cell death (>90%) 24
hours post pulse in all clones with identical electric field dependence. In all three clones,
A\|/m decrease was detected immediately (~ 1 min) after pulsing and was not blocked by
caspase inhibitor z-VAD-fmk or calpain inhibitor z-LLY-fmk or by the absence of
calcium or sodium. After 1.5-3 hour post pulse, cytochrome c release was observed but
was not inhibited by z-VAD-fmk or z-LLY-fmk and calpepetin; Caspase-9 was activated
before caspase-3/7 and caspase-8 was not significantly activated; H2AX phosphorylation
was inhibited by caspase inhibitor z-VAD-fmk; and cleavage of Bid was partially
blocked by calpain inhibitors (z-LLY-fmk and calpepetin). Taken together, these data
suggest near immediate, direct effects of nsPEFs on cell membranes followed by calpaindependent- and caspase-dependent-mechanisms through intrinsic pathways involving
cytochrome c release, presumed apoptosome-mediated caspase activation, calpain- and
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caspase-mediated Bid cleavage and apoptosis-mediated DNA double strand breaks.
These results demonstrate that apoptotic cell death induced by nsPEF was through the
intrinsic pathway.
INTRODUCTION
Nanosecond pulsed electric fields (nsPEFs) are non-ionizing, high power pulses
with pulse durations on the order of nanoseconds. Unlike conventional electroporation
pulses, which permeabilize the plasma membrane to facilitate delivery and uptake of
large molecules and drugs (154, 155), nsPEFs has been experimentally demonstrated to
induce nanopores with sizes less than 1-1.5 nm in all cell membranes (139, 140). NsPEFs
can manipulate intracellular structures and processes profoundly though supraelectroporation of cell members. The intracellular effects induced by nsPEFs include
phosphatidylserine (PS) translocation (150), calcium mobilization from intracellular and
extracellular sources (108, 109), nuclear DNA disruption (156), propidium iodide (PI)
uptake across the plasma membrane (157), and calcein uptake into subcellular granules
(104). Recently, nsPEFs has been shown to be a novel technology to effectively induce
nonthermal cell death by apoptosis both in vitro and in vivo (100, 101, 105, 114).
Apoptosis, a form of programmed cell death (PCD), is an essential process for
homeostasis maintenance and embryonic development. Deregulation of apoptosis
mechanisms has been implicated in pathogenesis of many diseases such as cancer.
Apoptosis is characterized by specific morphological and biochemical alterations of the
cell, including phosphatidyl serine (PS) externalization, cell shrinkage, chromatin
condensation, nucleosomal DNA fragmentation, and the disruption of mitochondrial
membrane potential with plasma membrane blebbing and formation of apoptotic bodies
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(1). The apoptotic cells are eventually recognized and phagocytosed by macrophages and
neighboring cells. Although apoptosis can occur through caspase-independent
mechanisms (10), activation of a cascade of highly homologous endopeptidases,
caspases, lies in a pivotal position for induction and execution of apoptosis (8, 9).
The apoptotic cascade can be initiated mainly through two distinct yet interrelated
pathways: the extrinsic (death receptor) pathway and intrinsic (mitochondrial) pathway.
The extrinsic pathway is activated through binding of death receptors (e.g. Fas/CD95,
TNFa- or TRAIL) by a cognate ligand or an agonistic antibody (e.g. CH-11 for Fas),
which induces multimerization of death receptors and recruitment of adaptor molecules
(e.g. FADD and TRADD) and pro-caspase-8 to the receptor complex to form the deathinducing signaling complex (DISC) (158, 159). Pro-caspase-8 is then activated by
proteolysis within the DISC (160). In type I cells, caspase-8 directly cleaves downstream
executioner pro-caspase-3. In type II cells, caspase-8 induces the cleavage of the BH3only protein Bid to generate truncated Bid (t-Bid), which in turn translocates to
mitochondria and with Bax or Bak stimulates the release of cytochrome c from
intermembrane space into cytosol (161). The intrinsic pathway is characterized by
mitochondrial damage and subsequent cytochrome c release (162). In the presence of
dATP/ATP, cytochrome c binds to Apaf-1 to assemble the "apoptosome", where procaspase-9 is activated by proteolysis. Consequently, caspase-9 activates downstream
executioner caspases and executes the final steps of apoptosis.
The intrinsic pathway was reported to be critical for caspase cascade activation in
Jurkat cells, classified as type II cells (24). Previous data suggested that it is difficult to
identify the apoptosis signaling pathways induced by nsPEFs in Jurkat cells due to the

56
coincidence of caspase activation and cytochrome c release (101). In this context, to
further understand the mechanisms of apoptosis induction by nsPEFs, we investigate the
involvement oft-Bid, mitochondria, caspase activation and H2AX phosphorylation
during nsPEF-induced apoptosis in Jurkat cells. It is herein shown that nsPEFs can induce
apoptosis in caspase-8-deficient and FADD-deficient Jurkat cells. Furthermore, both
caspase-dependent and caspase-independent calpain pathways are involved in the
regulation of nsPEF-induced apoptosis. In addition, evidence is provided for the first time
that nsPEFs induce apoptosis in Jurkat cells through the intrinsic pathway.
MATERIALS AND METHODS
Cell culture—Wild type Jurkat T-lymphocytes (clone A3) and mutant cell lines
deficient for FADD (clone I 2.1) or caspase-8 (clone I 9.2) were purchased from ATCC
(Manassas, VA). Clone A3 and I 9.2 were cultured in RPMI 1640 medium (ATCC)
containing 10% fetal bovine serum (FBS) (Atlanta Biologist), 1% L-glutamine and 1%
penicillin and streptomycin. Clone I 2.1 was maintained in RPMI 1640 medium (ATCC)
supplemented with 15% FBS, 1% L-glutamine and 1% penicillin and streptomycin. All
the cell lines were maintained in a humidified incubator with 5% C0 2 at 37°C. Use of the
Jurkat cell line does not constitute human subjects research.
Induction of cell death —Cells were resuspended in fresh culture medium at a
density of 7.7x106 cells/ml. 130ul of cell suspension was placed in a 0.1-cm gap-width
cuvette (Biosmith, San Diego, CA) and exposed to 60ns pulses ten times with electric
field strength ranging from 0 to 60kV/cm. The Frank Reidy Research Center for
Bioelectrics provides a course to present the safe use of high voltage pulse power
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equipment. The authors have been trained in the safe use of this equipment. In some
experiments, Jurkat clones were treated with CH-11, an agonistic anti-Fas antibody.
Determination of cell viability 24 hour post pulse—Jurkat cells were seeded at 10
cells per well in 96-well plates after pulsing. 24 hours after plating, cell viability was
measured by CellTiter-Glo Luminescent Cell Viability Assay (Promega, Madison, WI),
which determines viability by measuring ATP content of cells that is directly proportional
to cell number. The luminescent signal was analyzed with a microplate luminometer
(Gemini XPS, Molecular Devices, CA).
Determination of Caspase-3/7, -8, and -9 (-like) activities—Caspase-3/7, -8, and 9 (-like) catalytic activities were assayed using the Caspase-Glo-3/7,-8, -9 assay
(Promega, Madison, WI). According to manufacturer's instruction, cells were placed in
triplicate into 96-well plates at a density of 105 cells/well after pulsing. Plates were kept
at room temperature for 30 min and 100(0.1 of Caspase-Glo-3/7, -8, and -9 reagents
containing the selective luminogenic substrates z-DEVD, z-LETD, z-LEHD for caspase3/7, -8, -9 respectively, was then added into each well. Luminescence was read using a
microplate luminometer (Gemini XPS, Molecular Devices, CA) after 1 hour incubation at
room temperature.
Flow Cytometry Analysis of H2AX phosphorylation—Cells were harvested at
different time periods (1.5, 3, 6 hr) after nsPEFs treatment (60 kV/cm, 60 ns, 10 pulses)
and were resuspended in fixation/permeabilization solution (BD Cytofix/Cytoperm™ kit,
BD Biosciences) for 20 min at 4°C and after washing twice in lx BD Perm/Wash™
buffer, cells were then incubated with 1:100 diluted monoclonal anti-yH2AX (Serl39)
(Cell Signaling Technology) for 1 hr at 37°C and followed by incubation with a
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secondary Alexa 488-conjugated goat anti-rabbit IgG (1:200) for 45min at room
temperature (Molecular Probes, Invitrogen). After washing twice in BD Perm/Wash
buffer, the fluorescence of 10,000 cells was analyzed using a Becton Dickinson FacsAria
flow cytometer (488nm, FL-1).
Flow Cytometry Analysis of mitochondrial membrane potential
(Ay/m)—Depolarization of the mitochondrial membrane potential was detected using a
fluorescent lipophilic cation, tetramethylrhodamine ethyl ester (TMRE)
(Immunochemistry Technologies LLC). Cells were preincubated with 200 nM TMRE in
the presence or absence of 50 uM z-VAD-fmk, 50 uM z-LLY-fmk, 20 uM BAPTA-AM
(intracellular calcium chelator) and 5 mM EGTA (extracellular calcium chelator) for 20
min at 37°C. To determine A\|/m in the presence and absence of sodium, cells were
resuspended in Tyrode's buffer with sodium (NaCl, 145 mM; KC1, 5 mM;
MgS04-7H 2 0, 1 mM; Na2HP04, 0.4 mM; HEPES, 5 mM; glucose, 6 mM; pH 7.4) and
modified Tyrode's buffer with N-methyl-D-Glucamine (145 mM) substituted for sodium
(N-Methyl-D-Glucamine), for 20 min in the presence of 200 nM TMRE. At the end of
incubation, cells were resuspended in PBS, Tyrode's buffer, or modified Tyrode's buffer
and exposed to ten 60 ns pulses with 0 and 60 kV/cm electric fields. Flow cytometric
analysis was performed immediately (within 1 minute) after pulsing. In other experiments
A\|/m was determined at various times after treatment with nsPEFs. A separate analysis
included pulsing cells and then incubating with TMRE for 20 min before flow cytometric
analysis. The average intensity of red fluorescence (10,000 cells) was analyzed on the
FL-2 channel of a Becton Dickinson FacsAria flow cytometer.
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Flow Cytometry Analysis of cytochrome c release—Cytochrome c was assessed
using the Innocyte Flow Cytometric Cytochrome c Release assay (Calbiochem). At 0,
1.5,3,6 hour post pulse, cells were permeabilized for 10 min on ice, fixed with 8%
paraformaldehyde for 20 min at room temperature, washed with washing buffer
andresuspended in blocking buffer. Cells were then incubated with primary antibody for
lhour at 37°C and secondary antibody for 1 hour at room temperature. Cells (10,000)
were analyzed by Becton Dickinson Facs Aria flow cytometer.
Immunoblotting analysis—At specific time points after nsPEFs treatment, control
and nsPEFs treated cells were collected and washed with cold PBS once. Cell were lysed
in RIPA buffer (50mM Tris-HCL, 150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS) (Boston BioProducts) for 30min at 4°C. The lysates were centrifuged at
14,000 rpm for 20 min at 4°C, and the protein content in the supernatant was measured
using BCA assay kit (Pierce). Equal amounts of protein (50ixg) were separated by SDSpolyacrylamide gel electrophoresis, transferred to PVDF membranes and incubated with
a primary antibody to Bid/t-Bid (Cell signaling Technology, MA) at a dilution of 1:1000,
followed by IRDye680-conjugated secondary antibody (LI-COR Biosciences) in
blocking buffer for 1 hour. Protein-antibody complexes conjugated with IRDye 680 were
quantified on the Odyssey Infrared Imaging System (LI-COR Biosciences). P-Actin
(1:1000; Cell signaling Technology) was used as a loading control.
Statistical analysis—All experiments were performed at least three times
independently in this study. All the data were expressed as mean ± standard error (S.E.).
Statistical differences between control and treated groups were analyzed by a paired
Student's t-test (two-tailed) with/) < 0.05 regarded as statistically significant.
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RESULTS
NsPEFs induce cell death in an electric field-dependent manner in Jurkat cells in
vitro—To determine cell viability after nsPEF treatment, Jurkat clones were exposed to
ten 60 ns pulses of 0-60 kV/cm electric field strength. Cell viability was measured by
CellTiter Glo assay 24 hour post pulse. Results indicated that nsPEFs induced cell death
in all clones with identical electric field dependence when determined 24 hours post
pulse. Pulsing at 60 kV/cm resulted in <10% survival and an LD50 between 30 and 40
kV/cm in all three clones. Thus, cell death in Jurkat clones treated with lethal nsPEF
conditions was not dependent on the presence of FADD or caspase-8. As a comparison,
agonistic anti-Fas antibody (CH-11) was used to treat all three Jurkat clones. Cell death
was only found in wild type clone in a dose-dependent manner with the treatment of 50
ng/ml anti-Fas antibody (CH-11). Caspase-8 or FADD deficient clones survived
treatment with CH-11 antibody. These results indicate that the DISC is indispensable for
anti-Fas antibody-triggered cell death in Jurkat cells. We also used the CH-11 with
concentration higher 50 ng/ml to treat wild type clone, greater cell death response did not
occur (data not show), which indicates maximum cell death effect can be reached by
using 50 ng/ml CH-11.
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NsPEFs induce coordinated decreases in mitochondrial membrane potential
(Ay/m) and decreases in forward light scatter in Jurkat cells—To determine whether
mitochondrial membrane potential (A\|/m) decreased after nsPEF treatment and whether
A\)/m dissipation was a direct effect induced by nsPEFs, Jurkat WT clone A3 was
preincubated with TMRE followed by exposure to ten 60 ns pulses at 60 kV/cm. Flow
cytometry was performed within 1 minutes after pulsing. Results demonstrate that A\j/m
decrease immediately upon nsPEF treatment. About 54% of cell population exhibited
decreased A\|/m 1 min post pulse. As it was shown in Fig. 9, there was a time-dependent
increase in the number of cells with a decreased A\|/m; 87% of cell population show
dissipated A\|/m 1 hour post pulse.
It was also of interest to determine whether caspases, calpain, or the absence of
calcium affected A\|/m in response to nsPEFs. Jurkat clones were preincubated with zVAD-fmk, z-LLY-fmk, or EGTA/BAPTA-AM in growth media in the presence of
TMRE. Fig. 10 shows histogram plots and Fig. 11 shows contour plots of flow cytometry
experiments and Fig. 12 shows statistical comparisons of these results. Fig. 11 shows that
there is no significant difference between pretreated cell population and non-pretreated
population in response to nsPEFs, the A\|/m decrease is caspase- and calpain-independent.
Furthermore, the absence of calcium had no significant effect on nsPEF-induced A\|/m
disruption. Although there were no statistical difference in the presence and absence of
calcium, the histogram plots differences in cell distribution in the absence of calcium. In
the presence of calcium exposure to nsPEFs resulted in two populations of cells with
greater than 10-fold difference in TMRE fluorescence. In the absence of calcium there is
one broad population of cells instead of two distinct populations. Fig. 11 shows contour
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plots for correlation of the decreased A\|/m as indicated by decreases in TMRE
fluorescent intensity with a decrease in forward light scatter as a determinant of cell size.
At 60 kV/cm decreases in forward light scatter was coincident with A\|/m disruption
about 1 minute post pulse.
It was also interesting to determine if the presence of sodium was required for
dissipating A\|/m. Cells were, resuspended in Tyrode's buffer (with sodium) or modified
Tyrode's buffer (N-methyl-D-Glucamine substituted for sodium), and incubated with
TMRE to determine the sodium effect on A\|/m. The Av|/m dropped dramatically in
modified Tyrode's buffer (with N-methyl-D-Glucamine) compared to cells in Tyrode's
buffer. Most of the cell population (86.1 ±3.1%) showed decreased Av|/m within 1 minute
post pulse. Compared to cells in growth media, forward light scatter of cells in Tyrode's
buffer did not change dramatically; indicating Tyrode's buffer had minimal effects on
cell size. Together, the cell responses suggest that nsPEF-induced drop in A\|/m is a direct
effect that is independent of caspase and calpain activities or the presence of calcium and
sodium. The decrease in A\|/m was correlated with decreased cell size occurred
immediately after exposure to nsPEFs.
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FIGURE 9. NsPEFs depolarizes the mitochondrial membrane potential (Av|/m) in a time
dependent manner in Jurkat cells. Jurkat cells (wild type/clone A3) was preincubated with
TMRE for 20 min. Cells were then pulsed with ten 60 ns pulses at 60 kV/cm. Percentages of
cells with decreased A\|/m were determined by flow cytometry within 1 hour post pulse. Values
present one experiment.
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FIGURE 12. NsPEFs depolarizes the mitochondrial membrane potential (Avj/m) in Jurkat
cells. Jurkat cells (wild type/clone A3) was preincubated with TMRE for 20 min in the
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pulses at 60 kV/cm. Percentages of cells with decreased Av|/m were determined by flow
cytometry 1 min post pulse. Values present the mean ± SE (n=3). **p<0.01; ***/?< 0.001.

NsPEFs induce caspase-and calpain-independent cytochrome c release in a timedependent manner in Jurkat cells in vitro—The release of cytochrome c from
mitochondria is a critical event in the type II extrinsic and the intrinsic apoptosis
pathway. It initiates the assembly of the "apoptosome", which in turn actives procaspase-9 and subsequent activation of other caspases (163). To determine whether
cytochrome c was released and whether it depended on calpain or caspase, three Jurkat
clones were preloaded with the caspase inhibitor z-VAD-fmk, or calpain inhibitors zLLY-fmk, PD 150606 and calpeptin. Cytochrome c release was determined within the
first 6 hours post pulse using Innocyte flow cytometric cytochrome c release assay. Fig.

68
\3A shows cytochrome c release occurred between 1.5-3 hours post pulse in all three
clones in a time dependent manner. Moreover, Fig. 13B shows that there is no significant
difference among cytochrome c release in z-VAD-fmk-, z-LLY-fmk-, PD 150606-,
calpeptin- treated cells and non-treated cells, indicating cytochrome c release is through
caspase- and calpain-independent mechanisms in Jurkat cells.
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analyzed by flow cytometry. B, Jurkat clones were preincubated with 10 uM calpeptin, 20
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pulse using the InnoCyte Flow Cytometric cytochrome c release assay. A, The graph
represents the mean ± SE (n=3). B, The value represents one experimental result
conducted at 3 hours post pulse.

NsPEFs induce catalytic activities ofcaspsae-3/7, -9 in a time-dependent manner
in Jurkat cells—To determine whether executioner and initiator caspases are activated
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after nsPEF treatment, Jurkat clones were treated with ten 60 ns pulses at 60 kV/cm.
Caspase-3/7, -8, -9 activities using caspase isozyme-selective substrates were determined
by Caspase-Glo assay within 24 hours after nsPEF exposure. Results showed that nsPEFs
increased the catalytic activities of caspases-3/7, -9 proteases in (A) wild type, (B) FADD
deficient clone, and (C) caspase-8 deficient clone. Casapse-9 appeared to be activated
first in all three clones. The peak of caspases-9 activation is at approximately 6 hours post
pulse, whereas caspases-3 was activated dramatically at 9 hour post pulse in all three
clones. Caspase-9 and caspase-3 activities were the greatest in the FADD deficient clone
and the weakest in the caspase-8 deficient clone. Caspase-8 was only weakly activated in
the wild-type (like all type II cells) and FADD mutant and, as expected, caspase-8 was
essentially absent in the caspase-8 deficient mutant.
NsPEFs induce Bid cleavage to t-Bid in Jurkat cells in vitro—To determine
whether Bid is cleaved, we analyzed cells that were exposed to ten 60 ns pulses at 60
kV/cm and then analyzed them by immunoblot analysis using the Odyssey imaging
system to quantify the Bid and t-Bid levels at 0, 1.5, 3, 6 hours post pulse. Fig. 15^4
shows a typical immunoblot experiment of Bid and t-Bid in response to ten 60 ns pulses
at 60 kV/cm. Fig. 15B shows quantitative ratio of t-Bid/Actin over a 6-hour time course.
The results indicate that levels of Bid were decreased and t-Bid levels increased in all
clones, including the two mutants.
To determine the mechanisms by which Bid is cleaved, three Jurkat clones were
pretreated with z-VAD-fmk (pan-caspase inhibitor), z-IETD-fmk (caspase-8 inhibitor), zAEVD-fmk (caspase-10 inhibitor), z-LLY-fmk (general calpain inhibitor), PD 150606
(general calpain inhibitor), of calpeptin (general calpain inhibitor), followed by
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immunoblot analysis oft-Bid level 3 and 6 hour post pulse. Fig. 16 indicates that both
caspase and calpain contribute to Bid cleavage in nsPEF-induced cell death in Jurkat cells.
In AFADD clones, Bid cleavage reached the peak with the highest expression level oftBid compared to other two clones at 3 hours post pulse, the t-Bid level decreased at 6
hours post pulse. In the other two clones, more significant t-Bid expression occurred at 6
hours post pulse.
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FIGURE 15. NsPEFs induce Bid cleavage in a time-dependent manner in Jurkat
cells. Jurkat cells were exposed with or without ten 60 ns pulse at 60 kV/cm. Whole cell
extracts (50 ug protein) were separated by SDS-PAGE, transferred to PVDF membranes
and probed with an anti-Bid antibody. A, Bid (22kDa), t-Bid (15kDa) and Actin (45kDa)
levels were determined 0, 1.5, 3 and 6 hours post pulse by immunoblot analysis in a
representative experiment as described in Material and Methods. Quantification was
performed after normalizing t-Bid to Actin levels. B, Quantification of three experiments
like the typical one shown in A.
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NsPEFs induce caspases-dependent H2AX phosphorylation in a time-dependent
manner in Jurkat cells—DNA double-strand breaks (DSBs) are a type of DNA damage
in which two single-strand nicks in the complementary double helix of DNA occurs
simultaneously and sufficiently close to one another in locations, typically within 10-20
base pairs (77). The rapid phosphorylation of H2AX in the position of Ser-139 to form
yH2AX is an early event response to DSBs (78). To determine whether nsPEFs have
direct effect on DSBs, yH2AX was determined in the first minutes and hours after
treatment with nsPEFs. The presence of yH2AX was not observed until between 1.5 and
2 hours post pulse. H2AX phosphorylation was detected in a time-dependent manner. To
determine the caspase dependency of this event, three Jurkat clones were pretreated with
pan-caspase inhibitor z-VAD-fmk, and then pulsed ten times at 60 ns, 60 kV/cm in the
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presence of the inhibitor. yH2AX was determined 0, 1.5, 3 and 6 hours post pulse by flow
cytometry using anti-yH2AX (Ser-139) antibody. H2AX was not activated until between
1.5 and 3 hours post pulse. Fig. 17^4 shows typical histogram results with H2AX
fluorescence on the X-axis (FITC-A) and percentage of positive cells on the Y-axis. As
H2AX is phosphorylated, increases in fluorescent results in a shift of the cell population
to the right. Fig. \1B shows the combined results of three separate experiments with
statistical analysis. In control clones, very few cells showed H2AX phosphorylation,
whereas in treated cells, H2AX was significantly phosphorylated at 3-6 hours post pulse,
and the phosphorylation was completely inhibited by the pan-caspase inhibitor z-VADfmk.
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FIGURE 17. NsPEFs induce H2AX phosphorylation in a time-dependent manner in Jurkat
cells. Jurkat cells were exposed with or without ten 60 ns at 60kV/cm. yH2AX was detected with
antibodies as described inMaterials and Methods 0, 1.5,3,6 hour post pulse. A, Representative
histogram of yH2AX fluorescence (FITC-A) on the X-axis and cell count on the Y-axis. B, The
graph represents the mean ± SE with the percentage of cells exhibiting yH2AX (n=3). * p < 0.05;
**p<0.0\.
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DISCUSSION
The results presented here give us new insight into underlying mechanisms
inducing apoptosis in response to nsPEFs in three Jurkat clones. Cell death induced by
treatment with Fas antibody (CH-11) and nsPEFs appeared to be quite different in Jurkat
clones. CH-11 can only induce cell death in wild type in a dose-dependent manner,
whereas nsPEFs trigger cell demise in all three clones with identical electric-field
dependence. This suggested that as in Jurkat cells, death receptor aggregation and
subsequent DISC formation with Fas as death receptors and initiator caspase-8 were
indispensable for CH-11-induced cell death in Jurkat cells. However, DISC formation is
not required for cell death induced by nsPEFs. In E4 cells, the results reveal that nsPEFmediate cell death primarily though extrinsic-like pathways. However, in Jurkat clones,
cell death can be induced without FADD and caspase-8, which indicate death receptors
are likely not a mechanism for cell death induced by nsPEFs in Jurkat cells.
According to the response upon CD95/Fas triggering, Jurkat cells are defined as
type II cells (24). The mitochondria play a pivotal role in the apoptotic cell death of this
type of cell. As described above, we showed that nsPEFs perturbed the A\|/m rapidly in
Jurkat cells, indicating nsPEFs has direct effect on mitochondrial membranes. A wide
variety of evidences demonstrated that nsPEFs create nanopores on intracellular organelle
membranes, such as intracellular vesicles (104), endoplasmic reticulum (109), allowing
calcium release from intracellular stores (108, 109). Modeling results also indicate that
nsPEFs induce nanopores in cells (135-138). It is possible that nsPEFs porate the
mitochondrial inner memberane, resulting in mitochondrial inner membrane
depolarization immediate after pulsing.
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Moreover, the drop in A\|/m occurs even in the presence of a general caspase
inhibitor z-VAD-fmk, a general calpain inhibitor z-LLY-fmk, and calcium chelators
BAPTA and EGTA. This strongly suggested A\|/m decrease is a primary effect.
Furthermore, in the sodium free Tyrode's buffer, more cells showing decreased A\|/m
compared to cells in the Tyrode's buffer without sodium, indicating sodium plays a role
in maintenance of A\|/m. However, the increase in percentage of cells that exhibit
decreased Aym indicates a time-dependent biological response that is initiated by
nsPEFs. It has been shown previously that nsPEFs has differential effects on cells in Sphase, which exhibited greater membrane integrity (146). That is a possible reason for
different response time in terms of A\|/m disruption in the cell population. These studies
are carried out with cell in log phase growth, so a significant number of cells are expected
to be in S-phase. Another possibility is release of factors from cells that exhibited
decreases in A\|/m. ATP can be released from cells and act on P2Y receptors, which are
coupled to G-proteins leading to increases in intracellular IP3 and calcium. P2X receptors
are purinergic ligand gated channels. Puringergic P2Y and P2X receptors can trigger
specific chains of events which interact at the level of the individual elements both with
each other and with the transduction mechanisms of other receptors, creating a huge
diversity of the possible effects (164).
Our results showed that nsPEFs induced a rapid A\|/m decrease; whereas
cytochrome c was not released until 1.5-3 hours after nsPEF stimulation. NsPEFs induce
cytochrome c release might through operating mPTP. It has been shown that nsPEFs can
serves as a novel stimulus to open multiple types of voltage-gated Ca2+ channels in
chromaffin cells (165). It is possible that nsPEFs can manipulate mPTP through the outer
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membrane voltage-dependent anion channel (VDAC), ultimately open the mPTP. The
opening of the mPTP leads to mitochondrial permeability transition (mPT), as a result,
solutes (K+, Ma2+ and Ca2+ ions) and water enter the mitochondria, which results in
mitochondrial matrix swelling, rupture of the outer membrane and hence loss of
cytochrome c (166). In this study, the prompt A\j/m drop might lead to the cytochrome c
leak out of the mitochondria within 1.5-3 hours after nsPEF stimulation in Jurkat cells.
Alternatively, nsPEFs can induce cytochrome c release through Noxa/Puma (48, 49).
Upon DNA damage or other stresses, p53 will be activated through various pathways.
Noxa and Puma, which are direct transcriptional targets of p53, antagonize Bcl-2 function
and work upstreatm of Bax and Bak to promote mtiochondrial depolarization and
apoptosis (167). Our results indicated that nsPEFs can induce DNA double strand break
as was shown by yH2AX, and H2AX phosphorylation was coincident with cytochrome c
release. Noxa/Puma, transcribed following DNA damge-p53 induction, can interact with
anti-apoptotic Bcl-2 family members Bcl-2 and Bcl-xl, leading to cytochrome c release
(49).
Cytochrome c is the key player in apoptosis execution. Once released,
cytochrome c binds to Apaf-1 to form the "apoptosome", where pro-caspases-9 is
activated. Activated caspase-9 then proteolytically process the downstream pro-caspases3. Our results showed that cytochrome c release was coincident with caspase activation.
Caspase-9 activation occurred before caspase-3 was activated. Moreover, z-VAD-fmk,
PD 150606, z-LLY-fmk, calpeptin failed to inhibit the nsPEF-induced release of
cytochrome c from mitochondria in Jurkat clones, suggesting cytochrome c release was
independent of caspase and calpain activities. Taking all these results into consideration,
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we conclude that cytochrome c release, caspase-9 and -3 activation were through intrinsic
pathway in nsPEF-induced cell death in Jurkat cells.
We have shown previously that both calpain and caspase contributed to Bid
cleavage in nsPEF-induced cell death pathways (100). It has been shown that several
functionally distinct calpain inhibitors, such as calpeptin and PDl 50606 both blocked Bid
cleavage (44). In this study, immunoblotting results showed that Bid cleavage was
inhibited by several caspase inhibitors and calpain inhibitors. However, neither caspase
nor calpain interfere with cytochrome c release. This suggests that both calpain and
caspase might act downstream of cytochrome c release and Bid cleavage is downstream
of caspase and calpain activation.
It has been show previously that nsPEFs induce DNA damage in a wide variety of
cells (107, 123, 130, 156). However, the causative mechanisms are still unclear. In
B16fl0 melanoma, evidences suggested that initial DNA damage is caspase-independent.
yH2AX and TUNEL positive cells were present before caspase activation after nsPEF
treatment (114). Here, we defined the cause and effect relationships between active
caspases and yH2AX in Jurkat cells in response to nsPEFs. In this study, we showed that
H2AX was phosphorylated within 1.5-3 hours post pulse, which is coincident with
cytochrome c release and caspase activation. With the use of z-VAD-fmk, almost all the
yH2AX was inhibited within 6 hours, indicating H2AX phosphorylation is caspasedependent, and is downstream of caspase activities. It has been demonstrated that H2AX
phosphorylation depends directly on caspase action and CAD activation. Caspase can
active endonuclease CAD, release the DNase activity which causes DNA fragmentation
in nuclei (14, 168), ICAD can inhibit yH2AX in Jurkat cells (169).
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It is interesting that compared to the other clones; AFADD clone had greater
caspase-9 and-3 activities, more Bid cleavage and greater yH2AX. Bid and H2AX are
both caspase substrates, which suggests c-FLIP might compete with pro-caspase 8 first
and then bind to FADD leading to cell survival. AFADD clone had stronger cell death
effect in response to nsPEFs which might be the results of lacking the survival signal due
to the deleted of the FADD adaptor molecule, or FADD might have inhibitory role in
caspase activation and changes in caspase substrates.
Cancer treatment often fails at the cellular levels due to mutation of cancer cells
that cause evasion of apoptosis, multidrug resistance, and inhibition of signaling
molecules (122, 170, 171). Molecular mechanisms escaping apoptotic elimination can
also hinder localized physical therapies such as ionizing radiation as well as systemic
pharmaceutical interventions (172, 173). NsPEFs have been shown to be a powerful
technology for cancer treatment. It represents a local and drug-free treatment which leads
to non-thermal cell death by apoptosis. The advantage of such a mechanism to the tissue
would be that it removes damaged cells without the inflammation that necrosis would
bring. Several studies have demonstrated that nsPEFs can cause murine malignant
melanoma to complete self-destruct without recurrence (112-114, 124). The in vitro study
indicated the most significant differences between B16fl0 melanoma cells and Jurkat
cells is that cytochrome c was not released in melanoma cells in response to nsPEFinduced cell death, suggesting that a Bid-independent extrinsic pathway was exclusively
used to induce cell death (105).
Absence of apoptosis molecules expression such as FADD and caspase-8 could
confer multiple growth advantages on cancer cells, and is expected to contribute to
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disease progression. As a consequence, the ability of bypassing cancer mutations
represents a research field with potentially direct clinical applications. Our results here
clearly showed that nsPEFs triggered cell death through the intrinsic pathway in Jurkat
cells, bypassing DISC mutations, which provides advantage for treating cancers that
abrogate apoptosis through irregularities in DISC mechanisms. These mechanisms
provide molecular basis for nsPEFs as a potential alternative cancer treatment in the
future.
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CHAPTER IV
CONCLUSION

NsPEFs induce programmed cell death with apoptosis characteristics in several
cell lines in vitro, including mouse E4 SCC and three different human Jurkat clones. In
all cell lines, cell death was >90% at the highest electric field. However, E4 and Jurkat
cells exhibit very different nsPEFs sensitivities. While 60 kV/cm eliminated Jurkat cells
coincident with apoptosis markers with 60 ns pulse, E4 cells required pulses with
significantly longer pulse duration of 300 ns and 60 kV/cm. This is consistent with results
from Stacey et al. (156) who demonstrated that cell growing in suspension, like Jurkat
cell, was more sensitive to nsPEF than adherent cells, like E4 cells. In three Jurkat clones,
the cell death induced by nsPEFs showed identical electric field-dependence. Thus cell
death by nsPEFs was independent of the presence of caspase-8 and FADD and
consequently independent of DISC formation. Multiple common apoptosis markers such
as cell shrinkage, caspase activation, cytochrome c release, and A\|/m decrease were
observed in both cell lines; DNA double strand breaks was detected in Jurkat clones.
NsPEFs can activate multiple apoptosis pathways involving caspase- and calpaindependent and independent mechanisms, may or may not use cytochrome c release to
initiate apoptosis signaling. Depending on the cell type and electric field strength, the cell
responses to nsPEFs are distinct. In SCC, nsPEFs induce cell death primarily through
extrinsic-like pathways with smaller contributions from intrinsic-like pathways. Cell
death was coincident with PS externalization, caspase and calpain activation in the
presence and absence of cytochrome c release, decreases in Bid and A\|/m without
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apparent changes ROS levels or in Bcl-2 and Bcl-xl levels. In Jurkat cells, mitochondrialdependent intrinsic pathway is the primary cell death mechanism mediated by nsPEFs
without involvement of DISC, although FADD and caspase-8 appear to contribute to
several apoptosis markers. Cell death was accompanied with A\|/m dissipation,
cytochrome c release, downstream initiator caspase-9 and executioner caspase-3
activation, Bid cleavage, and DSBs.
Calcium-dependent calpain activation occurred in both cell lines after nsPEFtreatment. In SCC, Bid cleavage was caspase-dependent (55-60%) and calciumdependent (40-45%). Intracellular calcium and extracellular calcium was responsible for
about 30% and 70% of calcium dependence for Bid cleavage, respectively. In Jurkat
cells, although calpain inhibitor partially inhibits Bid cleavage as well, calpain inhibitors
do not interfere with cytochrome c release, indicating that in contrast to activation
through type II cell extrinsic pathway, Bid cleavage is downstream of cytochrome c
release. This again suggests intrinsic mechanisms for apoptosis induction in Jurkat cells.
These findings demonstrate that nsPEFs have profound effects on both plasma
membranes and intracellular membranes, including ER, mitochondria, nucleus and DNA.
NsPEFs also affect cell functions such as maintenance of plasma membrane potential,
A\|/m, ATP production, calcium mobilization, protease and DNAse activities. In addition
to these responses, nsPEFs have other advantages, such as the possibility to bypass
common mutations in cancer (105), the absence of systemic side effects, and minimally
invasive procedures with less scarring (112, 113). These features indicate that nsPEF can
potentially serve as a therapeutic tool that can modulate cellular programmed cell death
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mechanisms including apoptosis signaling to abolish evasion of apoptosis, an important
cancer hallmark and cancer therapeutic target.
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CHAPTER V
FUTURE STUDIES

The experimental data demonstrate that nsPEFs induce apoptosis primarily
through intrinsic pathway in Jurkat cells. The decrease in A\|/m occurred immediately
after nanopulsing, whereas cytochrome c was released within 1.5-3 hours post pulse. The
mechanisms by which nsPEFs induce cytochrome c release in Jurkat cells remain to be
determined. The Bcl-2 family members, either antiapoptotic or proapoptotic, regulate cell
death by controlling mitochondrial membrane permeability during apoptosis. Bcl-2 is
believed to prevent apoptosis by blocking cytochrome c release from mitochondria,
whereas, oligomerization of Bax/Bak promote apoptosis by facilitating cytochrome c
efflux (174). Conclusively indentify this mechanism requires analysis of Bcl-2 and
Bax/Bak expression level. Immunoblotting with quantification analysis of Bcl-2 and
Bax/Bak level can be conducted to indicate the role of Bcl-2 family proteins in nsPEFtriggered apoptosis. If Bcl-2 family members play a role in cytochrome c release, a
reduction in Bcl-2 expression accompanied with an increase in Bax/Bak level would be
expected to occur.
The cytochrome c release can be mediated through Noxa or Puma that are
activated by nuclear p53 via its transcriptional activity (48, 49). Also, cytosolic or
mitochondrial p53 can directly activate Bax/Bak via transcription-independent
mechanisms. Puma and Noxa are proapoptotic BH3-only Bcl-2 family members, and are
considered to indirectly induce mitochondrial outer membrane permeabilization (MOMP),
causing the efflux of mitochondrial death-promoting proteins including cytochrome c. To
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test the possibility that nsPEFs induce cytochrome c release indirectly by Noxa and (or)
Puma, Jurkat cells will be treated with nsPEFs and then Noxa and Puma expression level
will be examined by immunoblotting analysis over 6 hours post pulse.
Increasing evidences suggest that ROS produced by mitochondria play an
important role in stimulating cytochrome c release from cardiolipin. It is shown that ROS
causes cardiolipin oxidation, which assists the detachment of cytochrome c and its release
through the outer mitochondrial membrane into the cytosol. ROS may also be involved in
promoting mPT by oxidating part of the mPT pore (175). Our previous data showed that
ROS generation was not detected at any electric fields in both E4 and B16fl0 cells, those
cells may have potent antioxidant activity that protect against DNA and other damage
from ROS, are not expected to be effective in response to nsPEFs. However, information
could be gained by investigating the changes in the levels of nsPEF-triggered ROS
generation. Flow cytometric analysis using CM-H2DCFDA as a ROS indicator can be
performed to identify ROS level after pulsing. If nsPEFs induce ROS in Jurkat cells and
if E4 and B16fl0 cells protected against ROS detection, an increase in fluorescent
intensity is anticipated.
PS is translocated from the inner surface to the outer leaflet of the plasma
membrane during apoptosis, which can be identified by phospholipid-binding protein
Annexin V. PI is used to determine cell membrane integrity. The findings we obtained
demonstrate that nsPEFs have effects on both plasma membranes and intracellular
membranes. To determine the effect of nsPEFs on plasma membrane, flow cytometric
analysis of cells double labeled with Annexin V and PI can be conducted. Based on the
known effects of nsPEFs on plasma membrane nanoporation (140), results showing
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increases in the percentage of Annexin V positive and (or) PI positive cell populations are
anticipated.
It is not advisable to use PI as a viability marker given that electric fields have
transient and reversible effects on membrane permeability. Moreover, modeling evidence
indicates that nsPEFs can "pull" PS through nanopores (117, 147, 149, 150). Thus, PS
externalization should not be used as an apoptosis marker or used very cautiously when
evaluating effects of electric fields on plasma membranes.
It has been shown that nsPEFs cause caspase-dependent DSB as indicated by the
presence of phosphorylated H2AX (yH2AX) (See Fig. 17). It has been shown that DNA
damage may be directly caused by nsPEFs (114, 156). To determine whether nsPEFs
induce more general DNA damage and endonucleolytic DNA fragmentation are induced
by nsPEFs in Jurkat cells, terminal deoxynucleotidyl transferase (TdT)-mediated dUTP
nick-end labeling (TUNEL) can be used. The strand breaks can be identified by TdTcatalyzed attachment of fluorescein-dUTP to 3-OH' termini of cleaved DNA. If nsPEFinduced DSB are direct effects, they should be seen at early times after treatment, an
increase in the percentage of TUNEL positive cell population in nsPEF-treated cells
should be seen in the first minutes after treatment. DNA laddering can be used to assess
DNA fragmentation by agarose gel electrophoresis alternatively. Since H2AX
phosphorylation was z-VAD-fmk-sensitive, significant DNA laddering may be observed
after pulsing.
In normal cells, caspase-dependent increases in CAD and decreases in ICAD is
responsible for degrading the chromosomes into nucleosomal fragments as -180 base
pair (bp) fragments during apoptosis (73). To identify the DNA damage mechanisms
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induced by nsPEFs, immunoblotting with quantification analysis of ICAD level can be
performed after pulsing. Since yH2AX has been shown previously, a time-dependent
decrease in ICAD level with the occurrence of fragments pi 2 and p24 are expected to be
observed in Jurkat cells. .
Evidence has emerged that calcium-dependent calpain activation is responsible
for Bid cleavage in Jurkat cells. To further define the mechanisms for apoptosis in
response to nsPEFs, determination of calcium-dependent calpain activities can be done.
Calpain activities can be measured by fluorometric assay using AC-LLY- AFC as
substrate. Calcium can be quantified by flow cytometric analysis of fluo-4 (176). Based
on results from E4 cells and the calpain-inhibitor sensitive responses in Jurkat cells, it is
expected that time-dependent, calcium-dependent and calpain-inhibitor sensitive
increases in calpain activities will be observed. Any activity resistant to these inhibitors
would suggest other proteases such as cathepsins may be activated by nsPEFs.
It has been demonstrated that mitochondria play a crucial role in nsPEF-induced
apoptosis such that cytochrome c is released from mitochondria in both Jurkat cells and
E4 cells. To further support these findings, Apaf-1 deficient Jurkat cells can be used to
test the hypothesis. These cells will be treated with nsPEFs and then apoptosis markers,
such as caspase-9 and -3 catalytic activities will be tested. Since nsPEFs are expected to
act through the intrinsic pathway, the mutant Apaf-1 (AApaf-1) is supposed to block
caspase-9 and downstream caspase-3 activation, in addition, inhibition of ICAD cleavage
and H2AX phosphorylation. No significant caspase activities are expected to occur in
Apaf-1 deficient Jurkat cells after the treatment of nsPEFs.
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